In the last 12 months, insiders at NEUROCRINE BIOSCIENCES INC ($NBIX) filed 832 transactions with the SEC: 0 open-market purchases totaling $0 and 260 sales totaling $244,196,592. Net insider sentiment: net selling.
NEUROCRINE BIOSCIENCES INC operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- GORMAN KEVIN CHARLES (Director) — 31 transactions totaling $51,835,323
- BENEVICH ERIC (Chief Commercial Officer) — 70 transactions totaling $41,746,738
- GORMAN KEVIN CHARLES (Chief Executive Officer) — 24 transactions totaling $31,600,212
- ROBERTS EIRY (Chief Medical Officer) — 70 transactions totaling $26,716,140
- Onyia Jude (Chief Scientific Officer) — 52 transactions totaling $21,423,049
View all SEC Filings for NEUROCRINE BIOSCIENCES INC (NBIX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | ABERNETHY MATT | Chief Financial Officer | G | Common Stock | 2249 | $0.00 | 42,808.0000 | 102,500,000 | 4.99% | 0.00% |
| Feb. 20, 2026 | Onyia Jude | Chief Scientific Officer | G | Common Stock | 3110 | $0.00 | 25,670.0000 | 102,500,000 | 10.81% | 0.00% |
| Feb. 12, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1600 | $0.00 | 6,656.0000 | 102,500,000 | 31.65% | 0.00% |
| Feb. 12, 2026 | Delaet Ingrid | Chief Regulatory Officer | F | Common Stock | 881 | $123.10 | 5,775.0000 | 102,500,000 | 13.24% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1401 | $0.00 | 7,176.0000 | 102,500,000 | 24.26% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | F | Common Stock | 756 | $124.12 | 6,420.0000 | 102,500,000 | 10.54% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1359 | $0.00 | 7,779.0000 | 102,500,000 | 21.17% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | F | Common Stock | 734 | $124.12 | 7,045.0000 | 102,500,000 | 9.44% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | A | Common Stock | 19935 | $0.00 | 26,980.0000 | 102,500,000 | 282.97% | 0.02% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | F | Common Stock | 10755 | $124.12 | 16,225.0000 | 102,500,000 | 39.86% | 0.01% |
| Feb. 12, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Restricted Stock Unit | 1600 | $0.00 | 4,801.0000 | 102,500,000 | 25.00% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Restricted Stock Unit | 1401 | $0.00 | 2,802.0000 | 102,500,000 | 33.33% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Restricted Stock Unit | 1359 | $0.00 | 1,359.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | A | Stock Option | 31234 | $0.00 | 31,234.0000 | 102,500,000 | 9999.99% | 0.03% |
| Feb. 13, 2026 | Delaet Ingrid | Chief Regulatory Officer | A | Restricted Stock Unit | 5479 | $0.00 | 5,479.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 5604 | $0.00 | 522,497.0000 | 102,500,000 | 1.08% | 0.01% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | F | Common Stock | 3024 | $124.12 | 519,473.0000 | 102,500,000 | 0.58% | 0.00% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 5377 | $0.00 | 524,850.0000 | 102,500,000 | 1.04% | 0.01% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | F | Common Stock | 2901 | $124.12 | 521,949.0000 | 102,500,000 | 0.55% | 0.00% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | A | Common Stock | 63724 | $0.00 | 585,673.0000 | 102,500,000 | 12.21% | 0.06% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | F | Common Stock | 34380 | $124.12 | 551,293.0000 | 102,500,000 | 5.87% | 0.03% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | M | Restricted Stock Unit | 5604 | $0.00 | 11,208.0000 | 102,500,000 | 33.33% | 0.01% |
| Feb. 13, 2026 | GORMAN KEVIN CHARLES | Director | M | Restricted Stock Unit | 5377 | $0.00 | 5,377.0000 | 102,500,000 | 50.00% | 0.01% |
| Feb. 13, 2026 | Keswani Sanjay Chandru | Chief Medical Officer | A | Restricted Stock Unit | 6285 | $0.00 | 6,285.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 13, 2026 | Keswani Sanjay Chandru | Chief Medical Officer | A | Stock Option | 35827 | $0.00 | 35,827.0000 | 102,500,000 | 9999.99% | 0.03% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 2241 | $0.00 | 40,320.0000 | 102,500,000 | 5.89% | 0.00% |
| Feb. 12, 2026 | ABERNETHY MATT | Chief Financial Officer | F | Common Stock | 1151 | $123.10 | 38,079.0000 | 102,500,000 | 2.93% | 0.00% |
| Feb. 12, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 2133 | $0.00 | 6,401.0000 | 102,500,000 | 24.99% | 0.00% |
| Feb. 12, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 2133 | $0.00 | 39,230.0000 | 102,500,000 | 5.75% | 0.00% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | A | Restricted Stock Unit | 5479 | $0.00 | 5,479.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | A | Stock Option | 31234 | $0.00 | 31,234.0000 | 102,500,000 | 9999.99% | 0.03% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Restricted Stock Unit | 1811 | $0.00 | 1,812.0000 | 102,500,000 | 49.99% | 0.00% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Restricted Stock Unit | 1541 | $0.00 | 3,083.0000 | 102,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Restricted Stock Unit | 1600 | $0.00 | 4,801.0000 | 102,500,000 | 25.00% | 0.00% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | F | Common Stock | 5378 | $124.12 | 11,581.0000 | 102,500,000 | 31.71% | 0.01% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | A | Common Stock | 9968 | $0.00 | 16,959.0000 | 102,500,000 | 142.58% | 0.01% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | F | Common Stock | 978 | $124.12 | 6,991.0000 | 102,500,000 | 12.27% | 0.00% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 1811 | $0.00 | 7,969.0000 | 102,500,000 | 29.41% | 0.00% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | F | Common Stock | 832 | $124.12 | 6,158.0000 | 102,500,000 | 11.90% | 0.00% |
| Feb. 13, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 1541 | $0.00 | 6,990.0000 | 102,500,000 | 28.28% | 0.00% |
| Feb. 12, 2026 | Boyer David W. | Chief Corp. Affairs Officer | F | Common Stock | 864 | $123.10 | 5,449.0000 | 102,500,000 | 13.69% | 0.00% |
| Feb. 12, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 1600 | $0.00 | 6,313.0000 | 102,500,000 | 33.95% | 0.00% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | F | Common Stock | 5378 | $124.12 | 44,881.0000 | 102,500,000 | 10.70% | 0.01% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | A | Common Stock | 9968 | $0.00 | 50,259.0000 | 102,500,000 | 24.74% | 0.01% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | F | Common Stock | 1385 | $124.12 | 40,291.0000 | 102,500,000 | 3.32% | 0.00% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 2566 | $0.00 | 41,676.0000 | 102,500,000 | 6.56% | 0.00% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | F | Common Stock | 1210 | $124.12 | 39,110.0000 | 102,500,000 | 3.00% | 0.00% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 2241 | $0.00 | 4,484.0000 | 102,500,000 | 33.32% | 0.00% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 2566 | $0.00 | 2,566.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | A | Stock Option | 44095 | $0.00 | 44,095.0000 | 102,500,000 | 9999.99% | 0.04% |
| Feb. 13, 2026 | ABERNETHY MATT | Chief Financial Officer | A | Restricted Stock Unit | 7735 | $0.00 | 7,735.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 12, 2026 | Gano Kyle | Chief Executive Officer | M | Common Stock | 4907 | $0.00 | 146,661.0000 | 102,500,000 | 3.46% | 0.00% |
| Feb. 12, 2026 | Gano Kyle | Chief Executive Officer | F | Common Stock | 2648 | $123.10 | 144,013.0000 | 102,500,000 | 1.81% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | M | Common Stock | 2241 | $0.00 | 146,254.0000 | 102,500,000 | 1.56% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | F | Common Stock | 1210 | $124.12 | 145,044.0000 | 102,500,000 | 0.83% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | M | Common Stock | 2566 | $0.00 | 147,610.0000 | 102,500,000 | 1.77% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | F | Common Stock | 1385 | $124.12 | 146,225.0000 | 102,500,000 | 0.94% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | A | Common Stock | 9968 | $0.00 | 156,193.0000 | 102,500,000 | 6.82% | 0.01% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | F | Common Stock | 5378 | $124.12 | 150,815.0000 | 102,500,000 | 3.44% | 0.01% |
| Feb. 12, 2026 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 4907 | $0.00 | 14,721.0000 | 102,500,000 | 25.00% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 2241 | $0.00 | 4,484.0000 | 102,500,000 | 33.32% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 2566 | $0.00 | 2,566.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | A | Stock Option | 114830 | $0.00 | 114,830.0000 | 102,500,000 | 9999.99% | 0.11% |
| Feb. 13, 2026 | Gano Kyle | Chief Executive Officer | A | Restricted Stock Unit | 20142 | $0.00 | 20,142.0000 | 102,500,000 | 9999.99% | 0.02% |
| Feb. 12, 2026 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2560 | $0.00 | 18,537.0000 | 102,500,000 | 16.02% | 0.00% |
| Feb. 12, 2026 | Onyia Jude | Chief Scientific Officer | F | Common Stock | 1426 | $123.10 | 17,111.0000 | 102,500,000 | 7.69% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2690 | $0.00 | 19,801.0000 | 102,500,000 | 15.72% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | F | Common Stock | 1452 | $124.12 | 18,349.0000 | 102,500,000 | 7.33% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2717 | $0.00 | 21,066.0000 | 102,500,000 | 14.81% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | F | Common Stock | 1466 | $124.12 | 19,600.0000 | 102,500,000 | 6.96% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | A | Common Stock | 19935 | $0.00 | 39,535.0000 | 102,500,000 | 101.71% | 0.02% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | F | Common Stock | 10755 | $124.12 | 28,780.0000 | 102,500,000 | 27.20% | 0.01% |
| Feb. 12, 2026 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2560 | $0.00 | 7,681.0000 | 102,500,000 | 25.00% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2690 | $0.00 | 5,380.0000 | 102,500,000 | 33.33% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2717 | $0.00 | 2,717.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | A | Stock Option | 55119 | $0.00 | 55,119.0000 | 102,500,000 | 9999.99% | 0.05% |
| Feb. 13, 2026 | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 9669 | $0.00 | 9,669.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 12, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 2005 | $0.00 | 54,760.0000 | 102,500,000 | 3.80% | 0.00% |
| Feb. 12, 2026 | BENEVICH ERIC | Chief Commercial Officer | F | Common Stock | 1082 | $123.10 | 53,678.0000 | 102,500,000 | 1.98% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 1961 | $0.00 | 55,639.0000 | 102,500,000 | 3.65% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | F | Common Stock | 1058 | $124.12 | 54,581.0000 | 102,500,000 | 1.90% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 2083 | $0.00 | 56,664.0000 | 102,500,000 | 3.82% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | F | Common Stock | 1124 | $124.12 | 55,540.0000 | 102,500,000 | 1.98% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | A | Common Stock | 16613 | $0.00 | 72,153.0000 | 102,500,000 | 29.91% | 0.02% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | F | Common Stock | 8963 | $124.12 | 63,190.0000 | 102,500,000 | 12.42% | 0.01% |
| Feb. 12, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 2005 | $0.00 | 6,017.0000 | 102,500,000 | 24.99% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 1961 | $0.00 | 3,924.0000 | 102,500,000 | 33.32% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 2083 | $0.00 | 2,083.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | A | Stock Option | 36287 | $0.00 | 36,287.0000 | 102,500,000 | 9999.99% | 0.04% |
| Feb. 13, 2026 | BENEVICH ERIC | Chief Commercial Officer | A | Restricted Stock Unit | 6365 | $0.00 | 6,365.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 12, 2026 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1387 | $0.00 | 28,989.0000 | 102,500,000 | 5.02% | 0.00% |
| Feb. 12, 2026 | Cooke Julie | Chief Human Resources Officer | F | Common Stock | 749 | $123.10 | 28,240.0000 | 102,500,000 | 2.58% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1401 | $0.00 | 29,641.0000 | 102,500,000 | 4.96% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | F | Common Stock | 756 | $124.12 | 28,885.0000 | 102,500,000 | 2.55% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1510 | $0.00 | 30,395.0000 | 102,500,000 | 5.23% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | F | Common Stock | 815 | $124.12 | 29,580.0000 | 102,500,000 | 2.68% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | A | Common Stock | 9968 | $0.00 | 39,548.0000 | 102,500,000 | 33.70% | 0.01% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | F | Common Stock | 5378 | $124.12 | 34,170.0000 | 102,500,000 | 13.60% | 0.01% |
| Feb. 12, 2026 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1387 | $0.00 | 4,161.0000 | 102,500,000 | 25.00% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1401 | $0.00 | 2,802.0000 | 102,500,000 | 33.33% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1510 | $0.00 | 1,510.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | A | Stock Option | 27100 | $0.00 | 27,100.0000 | 102,500,000 | 9999.99% | 0.03% |
| Feb. 13, 2026 | Cooke Julie | Chief Human Resources Officer | A | Restricted Stock Unit | 4754 | $0.00 | 4,754.0000 | 102,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 1792 | $0.00 | 49,584.0000 | 102,500,000 | 3.75% | 0.00% |
| Feb. 12, 2026 | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 967 | $123.10 | 48,617.0000 | 102,500,000 | 1.95% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2017 | $0.00 | 50,634.0000 | 102,500,000 | 4.15% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 1089 | $124.12 | 49,545.0000 | 102,500,000 | 2.15% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2083 | $0.00 | 51,628.0000 | 102,500,000 | 4.20% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 1124 | $124.12 | 50,504.0000 | 102,500,000 | 2.18% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | A | Common Stock | 9968 | $0.00 | 60,472.0000 | 102,500,000 | 19.74% | 0.01% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 5378 | $124.12 | 55,094.0000 | 102,500,000 | 8.89% | 0.01% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | G | Common Stock | 365 | $0.00 | 54,729.0000 | 102,500,000 | 0.66% | 0.00% |
| Feb. 12, 2026 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 1792 | $0.00 | 5,377.0000 | 102,500,000 | 25.00% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2017 | $0.00 | 4,036.0000 | 102,500,000 | 33.32% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 34909 | $0.00 | 34,909.0000 | 102,500,000 | 9999.99% | 0.03% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2083 | $0.00 | 2,083.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 6124 | $0.00 | 6,124.0000 | 102,500,000 | 9999.99% | 0.01% |
| Jan. 31, 2026 | GORMAN KEVIN CHARLES | Director | F | Common Stock | 2845 | $136.06 | 516,893.0000 | 102,500,000 | 0.55% | 0.00% |
| Jan. 31, 2026 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 238 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | Onyia Jude | Chief Scientific Officer | F | Common Stock | 142 | $136.06 | 15,977.0000 | 102,500,000 | 0.88% | 0.00% |
| Jan. 31, 2026 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 238 | $0.00 | 16,119.0000 | 102,500,000 | 1.50% | 0.00% |
| Jan. 31, 2026 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2373 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 1335 | $136.06 | 47,792.0000 | 102,500,000 | 2.72% | 0.00% |
| Jan. 31, 2026 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2373 | $0.00 | 49,127.0000 | 102,500,000 | 5.08% | 0.00% |
| Jan. 31, 2026 | GORMAN KEVIN CHARLES | Director | M | Restricted Stock Unit | 5142 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.01% |
| Jan. 31, 2026 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 5142 | $0.00 | 519,738.0000 | 102,500,000 | 1.00% | 0.01% |
| Jan. 31, 2026 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 2927 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | Gano Kyle | Chief Executive Officer | F | Common Stock | 1580 | $136.06 | 141,754.0000 | 102,500,000 | 1.10% | 0.00% |
| Jan. 31, 2026 | Gano Kyle | Chief Executive Officer | M | Common Stock | 2927 | $0.00 | 143,334.0000 | 102,500,000 | 2.08% | 0.00% |
| Jan. 31, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Restriced Stock Unit | 801 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | Delaet Ingrid | Chief Regulatory Officer | F | Common Stock | 475 | $136.06 | 5,056.0000 | 102,500,000 | 8.59% | 0.00% |
| Jan. 31, 2026 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 801 | $0.00 | 5,531.0000 | 102,500,000 | 16.93% | 0.00% |
| Jan. 31, 2026 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1741 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | Cooke Julie | Chief Human Resources Officer | F | Common Stock | 997 | $136.06 | 27,602.0000 | 102,500,000 | 3.49% | 0.00% |
| Jan. 31, 2026 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1741 | $0.00 | 28,599.0000 | 102,500,000 | 6.48% | 0.00% |
| Jan. 31, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 2437 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | ABERNETHY MATT | Chief Financial Officer | F | Common Stock | 1368 | $136.06 | 37,097.0000 | 102,500,000 | 3.56% | 0.00% |
| Jan. 31, 2026 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 2437 | $0.00 | 38,465.0000 | 102,500,000 | 6.76% | 0.00% |
| Jan. 31, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 2294 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | BENEVICH ERIC | Chief Commercial Officer | F | Common Stock | 1292 | $136.06 | 52,755.0000 | 102,500,000 | 2.39% | 0.00% |
| Jan. 31, 2026 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 2294 | $0.00 | 54,047.0000 | 102,500,000 | 4.43% | 0.00% |
| Jan. 31, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Restriced Stock Unit | 2096 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | Boyer David W. | Chief Corp. Affairs Officer | F | Common Stock | 1189 | $136.06 | 4,713.0000 | 102,500,000 | 20.15% | 0.00% |
| Jan. 31, 2026 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 2096 | $0.00 | 5,902.0000 | 102,500,000 | 55.07% | 0.00% |
| Jan. 16, 2026 | Gano Kyle | Chief Executive Officer | S | Common Stock | 34588 | $132.70 | 140,407.0000 | 102,500,000 | 19.77% | 0.03% |
| Jan. 16, 2026 | Gano Kyle | Chief Executive Officer | M | Non-Qualified Stock Option | 34588 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.03% |
| Jan. 16, 2026 | Gano Kyle | Chief Executive Officer | S | Common Stock | 1812 | $132.71 | 140,407.0000 | 102,500,000 | 1.27% | 0.00% |
| Jan. 16, 2026 | Gano Kyle | Chief Executive Officer | M | Common Stock | 1812 | $35.99 | 142,219.0000 | 102,500,000 | 1.29% | 0.00% |
| Jan. 16, 2026 | Gano Kyle | Chief Executive Officer | M | Common Stock | 34588 | $35.99 | 174,995.0000 | 102,500,000 | 24.63% | 0.03% |
| Jan. 16, 2026 | Gano Kyle | Chief Executive Officer | M | Incentive Stock Option | 1812 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Nov. 28, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Incentive Stock Option | 12830 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.01% |
| Nov. 28, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 12830 | $35.99 | 109,476.0000 | 102,500,000 | 13.28% | 0.01% |
| Jan. 8, 2026 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 3349 | $35.99 | 46,754.0000 | 102,500,000 | 7.72% | 0.00% |
| Jan. 8, 2026 | Lippoldt Darin | Chief Legal Officer | M | Incentive Stock Option | 3349 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Dec. 15, 2025 | Norwalk Leslie V | Director | M | Common Stock | 8276 | $92.35 | 10,705.0000 | 102,500,000 | 340.72% | 0.01% |
| Dec. 16, 2025 | Norwalk Leslie V | Director | S | Common Stock | 1190 | $155.09 | 6,239.0000 | 102,500,000 | 16.02% | 0.00% |
| Dec. 15, 2025 | Norwalk Leslie V | Director | S | Common Stock | 5000 | $152.23 | 7,429.0000 | 102,500,000 | 40.23% | 0.00% |
| Dec. 15, 2025 | Norwalk Leslie V | Director | M | Common Stock | 1724 | $84.95 | 12,429.0000 | 102,500,000 | 16.10% | 0.00% |
| Dec. 15, 2025 | Norwalk Leslie V | Director | M | Non-Qualified Stock Option | 1724 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Dec. 15, 2025 | Norwalk Leslie V | Director | M | Non-Qualified Stock Option | 8276 | $0.00 | 557.0000 | 102,500,000 | 93.69% | 0.01% |
| Dec. 8, 2025 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 4376 | $159.65 | 43,405.0000 | 102,500,000 | 9.16% | 0.00% |
| Dec. 8, 2025 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 4376 | $43.24 | 47,781.0000 | 102,500,000 | 10.08% | 0.00% |
| Dec. 8, 2025 | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 4376 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Dec. 3, 2025 | LYONS GARY A | Director | S | Common Stock | 15000 | $152.61 | 120,482.0000 | 102,500,000 | 11.07% | 0.01% |
| Dec. 3, 2025 | LYONS GARY A | Director | M | Common Stock | 15000 | $47.89 | 135,482.0000 | 102,500,000 | 12.45% | 0.01% |
| Dec. 3, 2025 | LYONS GARY A | Director | M | Non-Qualified Stock Option | 15000 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.01% |
| Nov. 28, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 5970 | $35.99 | 50,863.0000 | 102,500,000 | 13.30% | 0.01% |
| Nov. 29, 2025 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 4426 | $0.00 | 18,129.0000 | 102,500,000 | 32.30% | 0.00% |
| Nov. 29, 2025 | Onyia Jude | Chief Scientific Officer | F | Common Stock | 2248 | $152.16 | 15,881.0000 | 102,500,000 | 12.40% | 0.00% |
| Nov. 29, 2025 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 4426 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Nov. 28, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Incentive Stock Option | 5970 | $0.00 | 6,860.0000 | 102,500,000 | 46.53% | 0.01% |
| Nov. 28, 2025 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 5970 | $151.74 | 44,893.0000 | 102,500,000 | 11.74% | 0.01% |
| Nov. 25, 2025 | MORROW GEORGE J | Director | M | Common Stock | 15000 | $47.89 | 22,068.0000 | 102,500,000 | 212.22% | 0.01% |
| Nov. 25, 2025 | MORROW GEORGE J | Director | M | Non-Qualified Stock Option | 15000 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.01% |
| Nov. 25, 2025 | MORROW GEORGE J | Director | S | Common Stock | 15000 | $143.37 | 7,068.0000 | 102,500,000 | 67.97% | 0.01% |
| Nov. 5, 2025 | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 18000 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.02% |
| Nov. 5, 2025 | RASTETTER WILLIAM H | Director | S | Common Stock | 18000 | $151.82 | 40,360.0000 | 102,500,000 | 30.84% | 0.02% |
| Nov. 5, 2025 | RASTETTER WILLIAM H | Director | M | Common Stock | 18000 | $47.89 | 58,360.0000 | 102,500,000 | 44.60% | 0.02% |
| Nov. 1, 2025 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 613 | $0.00 | 1,842.0000 | 102,500,000 | 24.97% | 0.00% |
| Nov. 1, 2025 | Gano Kyle | Chief Executive Officer | M | Common Stock | 613 | $0.00 | 140,720.0000 | 102,500,000 | 0.44% | 0.00% |
| Nov. 4, 2025 | Gano Kyle | Chief Executive Officer | S | Common Stock | 300 | $141.97 | 140,407.0000 | 102,500,000 | 0.21% | 0.00% |
| Sept. 3, 2025 | Onyia Jude | Chief Scientific Officer | G | Common Stock | 1470 | $0.00 | 13,703.0000 | 103,700,000 | 9.69% | 0.00% |
| Sept. 2, 2025 | SHERWIN STEPHEN A | Director | G | Common Stock | 1000 | $0.00 | 12,542.0000 | 103,700,000 | 7.38% | 0.00% |
| Aug. 7, 2025 | GORMAN KEVIN CHARLES | Director | M | Non-Qualified Stock Option | 106322 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.10% |
| Aug. 7, 2025 | GORMAN KEVIN CHARLES | Director | S | Common Stock | 106322 | $126.41 | 514,596.0000 | 103,700,000 | 17.12% | 0.10% |
| Aug. 7, 2025 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 106322 | $35.99 | 620,918.0000 | 103,700,000 | 20.66% | 0.10% |
| Aug. 5, 2025 | Onyia Jude | Chief Scientific Officer | G | Common Stock | 3116 | $0.00 | 15,173.0000 | 103,700,000 | 17.04% | 0.00% |
| July 10, 2025 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 457 | $135.00 | 4,730.0000 | 103,700,000 | 8.81% | 0.00% |
| July 10, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 457 | $79.02 | 5,187.0000 | 103,700,000 | 9.66% | 0.00% |
| July 9, 2025 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 59819 | $130.46 | 18,289.0000 | 103,700,000 | 76.58% | 0.06% |
| July 9, 2025 | Onyia Jude | Chief Scientific Officer | M | Non-Qualified Stock Option | 59819 | $0.00 | 35,268.0000 | 103,700,000 | 62.91% | 0.06% |
| July 9, 2025 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 59819 | $84.74 | 78,108.0000 | 103,700,000 | 327.08% | 0.06% |
| July 10, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 457 | $0.00 | 2,261.0000 | 103,700,000 | 16.81% | 0.00% |
| July 2, 2025 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 20362 | $84.74 | 38,651.0000 | 103,700,000 | 111.33% | 0.02% |
| July 2, 2025 | Onyia Jude | Chief Scientific Officer | M | Non-Qualified Stock Option | 20362 | $0.00 | 95,087.0000 | 103,700,000 | 17.64% | 0.02% |
| July 2, 2025 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 20362 | $130.13 | 18,289.0000 | 103,700,000 | 52.68% | 0.02% |
| June 2, 2025 | Keswani Sanjay Chandru | Chief Medical Officer | A | Stock Option | 70101 | $0.00 | 70,101.0000 | 103,700,000 | 9999.99% | 0.07% |
| June 2, 2025 | Keswani Sanjay Chandru | Chief Medical Officer | A | Restricted Stock Unit | 12846 | $0.00 | 12,846.0000 | 103,700,000 | 9999.99% | 0.01% |
| May 27, 2025 | GORMAN KEVIN CHARLES | Director | S | Common Stock | 9613 | $120.38 | 514,596.0000 | 103,700,000 | 1.83% | 0.01% |
| May 22, 2025 | MORROW GEORGE J | Director | M | Common Stock | 2869 | $0.00 | 7,068.0000 | 103,700,000 | 68.33% | 0.00% |
| May 22, 2025 | POPS RICHARD F | Director | M | Restricted Stock Unit | 2869 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | MORROW GEORGE J | Director | M | Restricted Stock Unit | 2869 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | LYONS GARY A | Director | M | Common Stock | 1435 | $0.00 | 120,482.0000 | 103,700,000 | 1.21% | 0.00% |
| May 21, 2025 | LYONS GARY A | Director | A | Restricted Stock Unit | 1659 | $0.00 | 1,659.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 21, 2025 | LYONS GARY A | Director | A | Non-Qualified Stock Option | 3305 | $0.00 | 3,305.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | LYONS GARY A | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | Norwalk Leslie V | Director | M | Common Stock | 1435 | $0.00 | 2,429.0000 | 103,700,000 | 144.37% | 0.00% |
| May 21, 2025 | Norwalk Leslie V | Director | A | Restricted Stock Unit | 1659 | $0.00 | 1,659.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 21, 2025 | Norwalk Leslie V | Director | A | Non-Qualified Stock Option | 3305 | $0.00 | 3,305.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | Norwalk Leslie V | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | Mercier Johanna | Director | M | Common Stock | 1435 | $0.00 | 3,535.0000 | 103,700,000 | 68.33% | 0.00% |
| May 21, 2025 | Mercier Johanna | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | Mercier Johanna | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 21, 2025 | MORROW GEORGE J | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | SHERWIN STEPHEN A | Director | M | Common Stock | 2869 | $0.00 | 13,542.0000 | 103,700,000 | 26.88% | 0.00% |
| May 21, 2025 | SHERWIN STEPHEN A | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | SHERWIN STEPHEN A | Director | M | Restricted Stock Unit | 2869 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | POPS RICHARD F | Director | M | Common Stock | 2869 | $0.00 | 34,480.0000 | 103,700,000 | 9.08% | 0.00% |
| May 21, 2025 | POPS RICHARD F | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | RASTETTER WILLIAM H | Director | M | Common Stock | 2869 | $0.00 | 40,360.0000 | 103,700,000 | 7.65% | 0.00% |
| May 21, 2025 | RASTETTER WILLIAM H | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | RASTETTER WILLIAM H | Director | M | Restricted Stock Unit | 2869 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | POON CHRISTINE A | Director | M | Common Stock | 1435 | $0.00 | 1,435.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 21, 2025 | POON CHRISTINE A | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | POON CHRISTINE A | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 21, 2025 | GORMAN KEVIN CHARLES | Director | A | Non-Qualified Stock Option | 6610 | $0.00 | 6,610.0000 | 103,700,000 | 9999.99% | 0.01% |
| May 22, 2025 | Sharp Shalini | Director | M | Common Stock | 1435 | $0.00 | 2,429.0000 | 103,700,000 | 144.37% | 0.00% |
| May 21, 2025 | Sharp Shalini | Director | A | Restricted Stock Unit | 1659 | $0.00 | 1,659.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 21, 2025 | Sharp Shalini | Director | A | Non-Qualified Stock Option | 3305 | $0.00 | 3,305.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | Sharp Shalini | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 16, 2025 | Cooke Julie | Chief Human Resources Officer | M | Incentive Stock Option | 6468 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.01% |
| May 16, 2025 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 6468 | $61.82 | 26,858.0000 | 103,700,000 | 31.72% | 0.01% |
| May 5, 2025 | RASTETTER WILLIAM H | Director | M | Common Stock | 30000 | $42.76 | 67,491.0000 | 103,700,000 | 80.02% | 0.03% |
| May 5, 2025 | RASTETTER WILLIAM H | Director | S | Common Stock | 30000 | $110.20 | 37,491.0000 | 103,700,000 | 44.45% | 0.03% |
| May 5, 2025 | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 30000 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.03% |
| Feb. 13, 2025 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 716 | $116.69 | 4,084.0000 | 103,700,000 | 14.92% | 0.00% |
| Feb. 13, 2025 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1509 | $0.00 | 20,340.0000 | 103,700,000 | 8.01% | 0.00% |
| Feb. 13, 2025 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 796 | $116.77 | 19,544.0000 | 103,700,000 | 3.91% | 0.00% |
| Feb. 13, 2025 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1401 | $0.00 | 20,945.0000 | 103,700,000 | 7.17% | 0.00% |
| Feb. 13, 2025 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 755 | $116.80 | 20,190.0000 | 103,700,000 | 3.60% | 0.00% |
| Feb. 12, 2025 | Cooke Julie | Chief Human Resources Officer | A | Stock Option | 29600 | $0.00 | 29,600.0000 | 103,700,000 | 9999.99% | 0.03% |
| Feb. 12, 2025 | Cooke Julie | Chief Human Resources Officer | A | Restricted Stock Unit | 5548 | $0.00 | 5,548.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1509 | $0.00 | 3,020.0000 | 103,700,000 | 33.32% | 0.00% |
| Feb. 13, 2025 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1401 | $0.00 | 4,203.0000 | 103,700,000 | 25.00% | 0.00% |
| Feb. 13, 2025 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 5376 | $0.00 | 524,450.0000 | 103,700,000 | 1.04% | 0.01% |
| Feb. 13, 2025 | GORMAN KEVIN CHARLES | Director | S | Common Stock | 2832 | $116.69 | 521,618.0000 | 103,700,000 | 0.54% | 0.00% |
| Feb. 13, 2025 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 5603 | $0.00 | 527,221.0000 | 103,700,000 | 1.07% | 0.01% |
| Feb. 13, 2025 | GORMAN KEVIN CHARLES | Director | S | Common Stock | 3012 | $116.68 | 524,209.0000 | 103,700,000 | 0.57% | 0.00% |
| Feb. 13, 2025 | GORMAN KEVIN CHARLES | Director | M | Restricted Stock Unit | 5376 | $0.00 | 10,754.0000 | 103,700,000 | 33.33% | 0.01% |
| Feb. 13, 2025 | GORMAN KEVIN CHARLES | Director | M | Restricted Stock Unit | 5603 | $0.00 | 16,812.0000 | 103,700,000 | 25.00% | 0.01% |
| Feb. 13, 2025 | SHERWIN STEPHEN A | Director | S | Common Stock | 13831 | $116.69 | 10,673.0000 | 103,700,000 | 56.44% | 0.01% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 2113 | $0.00 | 35,366.0000 | 103,700,000 | 6.35% | 0.00% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1114 | $116.90 | 34,252.0000 | 103,700,000 | 3.15% | 0.00% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1120 | $0.00 | 35,372.0000 | 103,700,000 | 3.27% | 0.00% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 604 | $116.74 | 34,768.0000 | 103,700,000 | 1.71% | 0.00% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1372 | $0.00 | 36,140.0000 | 103,700,000 | 3.95% | 0.00% |
| Feb. 14, 2025 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 500 | $115.04 | 35,640.0000 | 103,700,000 | 1.38% | 0.00% |
| Feb. 12, 2025 | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 43261 | $0.00 | 43,261.0000 | 103,700,000 | 9999.99% | 0.04% |
| Feb. 12, 2025 | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 8108 | $0.00 | 8,108.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 2113 | $0.00 | 4,227.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 1120 | $0.00 | 3,363.0000 | 103,700,000 | 24.98% | 0.00% |
| Feb. 13, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 1372 | $0.00 | 4,115.0000 | 103,700,000 | 25.00% | 0.00% |
| Feb. 13, 2025 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2717 | $0.00 | 18,278.0000 | 103,700,000 | 17.46% | 0.00% |
| Feb. 13, 2025 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 1432 | $116.83 | 16,846.0000 | 103,700,000 | 7.83% | 0.00% |
| Feb. 13, 2025 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 2690 | $0.00 | 19,536.0000 | 103,700,000 | 15.97% | 0.00% |
| Feb. 13, 2025 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 1447 | $116.75 | 18,089.0000 | 103,700,000 | 7.41% | 0.00% |
| Feb. 12, 2025 | Onyia Jude | Chief Scientific Officer | A | Stock Option | 54645 | $0.00 | 54,645.0000 | 103,700,000 | 9999.99% | 0.05% |
| Feb. 12, 2025 | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 10241 | $0.00 | 10,241.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2717 | $0.00 | 5,434.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 2690 | $0.00 | 8,070.0000 | 103,700,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | Lippoldt Darin | Chief Legal Officer | G | Common Stock | 190 | $0.00 | 41,489.0000 | 103,700,000 | 0.46% | 0.00% |
| Feb. 13, 2025 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2083 | $0.00 | 43,572.0000 | 103,700,000 | 5.02% | 0.00% |
| Feb. 13, 2025 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1098 | $116.76 | 42,474.0000 | 103,700,000 | 2.52% | 0.00% |
| Feb. 13, 2025 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2017 | $0.00 | 44,491.0000 | 103,700,000 | 4.75% | 0.00% |
| Feb. 13, 2025 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1086 | $116.75 | 43,405.0000 | 103,700,000 | 2.44% | 0.00% |
| Feb. 12, 2025 | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 38252 | $0.00 | 38,252.0000 | 103,700,000 | 9999.99% | 0.04% |
| Feb. 12, 2025 | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 7169 | $0.00 | 7,169.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2083 | $0.00 | 4,166.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2017 | $0.00 | 6,053.0000 | 103,700,000 | 24.99% | 0.00% |
| Feb. 13, 2025 | Gano Kyle | Chief Executive Officer | M | Common Stock | 2566 | $0.00 | 140,224.0000 | 103,700,000 | 1.86% | 0.00% |
| Feb. 13, 2025 | Gano Kyle | Chief Executive Officer | S | Common Stock | 1352 | $116.84 | 138,872.0000 | 103,700,000 | 0.96% | 0.00% |
| Feb. 13, 2025 | Gano Kyle | Chief Executive Officer | M | Common Stock | 2241 | $0.00 | 141,113.0000 | 103,700,000 | 1.61% | 0.00% |
| Feb. 13, 2025 | Gano Kyle | Chief Executive Officer | S | Common Stock | 1206 | $116.86 | 139,907.0000 | 103,700,000 | 0.85% | 0.00% |
| Feb. 12, 2025 | Gano Kyle | Chief Executive Officer | A | Stock Option | 104736 | $0.00 | 104,736.0000 | 103,700,000 | 9999.99% | 0.10% |
| Feb. 12, 2025 | Gano Kyle | Chief Executive Officer | A | Restricted Stock Unit | 19628 | $0.00 | 19,628.0000 | 103,700,000 | 9999.99% | 0.02% |
| Feb. 13, 2025 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 2566 | $0.00 | 5,132.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 2241 | $0.00 | 6,725.0000 | 103,700,000 | 24.99% | 0.00% |
| Feb. 13, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1358 | $0.00 | 4,800.0000 | 103,700,000 | 39.45% | 0.00% |
| Feb. 13, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1401 | $0.00 | 5,485.0000 | 103,700,000 | 34.30% | 0.00% |
| Feb. 13, 2025 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 755 | $116.72 | 4,730.0000 | 103,700,000 | 13.76% | 0.00% |
| Feb. 12, 2025 | Delaet Ingrid | Chief Regulatory Officer | A | Stock Option | 34153 | $0.00 | 34,153.0000 | 103,700,000 | 9999.99% | 0.03% |
| Feb. 12, 2025 | Delaet Ingrid | Chief Regulatory Officer | A | Restricted Stock Unit | 6401 | $0.00 | 6,401.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Restricted Stock Unit | 1358 | $0.00 | 2,718.0000 | 103,700,000 | 33.32% | 0.00% |
| Feb. 13, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Restricted Stock Unit | 1401 | $0.00 | 4,203.0000 | 103,700,000 | 25.00% | 0.00% |
| Feb. 13, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 1811 | $0.00 | 3,809.0000 | 103,700,000 | 90.64% | 0.00% |
| Feb. 13, 2025 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 955 | $116.79 | 2,854.0000 | 103,700,000 | 25.07% | 0.00% |
| Feb. 13, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 1541 | $0.00 | 4,395.0000 | 103,700,000 | 53.99% | 0.00% |
| Feb. 13, 2025 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 830 | $116.69 | 3,565.0000 | 103,700,000 | 18.89% | 0.00% |
| Feb. 12, 2025 | Boyer David W. | Chief Corp. Affairs Officer | A | Stock Option | 34153 | $0.00 | 34,153.0000 | 103,700,000 | 9999.99% | 0.03% |
| Feb. 12, 2025 | Boyer David W. | Chief Corp. Affairs Officer | A | Restricted Stock Unit | 6401 | $0.00 | 6,401.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Restricted Stock Unit | 1811 | $0.00 | 3,623.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Restricted Stock Unit | 1541 | $0.00 | 4,624.0000 | 103,700,000 | 25.00% | 0.00% |
| Feb. 13, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 2083 | $0.00 | 44,882.0000 | 103,700,000 | 4.87% | 0.00% |
| Feb. 13, 2025 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1098 | $116.74 | 43,784.0000 | 103,700,000 | 2.45% | 0.00% |
| Feb. 13, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 1961 | $0.00 | 45,745.0000 | 103,700,000 | 4.48% | 0.00% |
| Feb. 13, 2025 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1056 | $116.71 | 44,689.0000 | 103,700,000 | 2.31% | 0.00% |
| Feb. 12, 2025 | BENEVICH ERIC | Chief Commercial Officer | A | Stock Option | 42805 | $0.00 | 42,805.0000 | 103,700,000 | 9999.99% | 0.04% |
| Feb. 12, 2025 | BENEVICH ERIC | Chief Commercial Officer | A | Restricted Stock Unit | 8022 | $0.00 | 8,022.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 2083 | $0.00 | 4,166.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 1961 | $0.00 | 5,885.0000 | 103,700,000 | 24.99% | 0.00% |
| Feb. 13, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 2566 | $0.00 | 36,127.0000 | 103,700,000 | 7.65% | 0.00% |
| Feb. 13, 2025 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1352 | $116.85 | 34,775.0000 | 103,700,000 | 3.74% | 0.00% |
| Feb. 13, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 2241 | $0.00 | 37,016.0000 | 103,700,000 | 6.44% | 0.00% |
| Feb. 13, 2025 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1206 | $116.87 | 35,810.0000 | 103,700,000 | 3.26% | 0.00% |
| Feb. 12, 2025 | ABERNETHY MATT | Chief Financial Officer | A | Stock Option | 45538 | $0.00 | 45,538.0000 | 103,700,000 | 9999.99% | 0.04% |
| Feb. 12, 2025 | ABERNETHY MATT | Chief Financial Officer | A | Restricted Stock Unit | 8534 | $0.00 | 8,534.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 2566 | $0.00 | 5,132.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 2241 | $0.00 | 6,725.0000 | 103,700,000 | 24.99% | 0.00% |
| Feb. 8, 2025 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1329 | $0.00 | 19,531.0000 | 103,700,000 | 7.30% | 0.00% |
| Feb. 8, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 1860 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 980 | $118.27 | 33,561.0000 | 103,700,000 | 2.84% | 0.00% |
| Feb. 8, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 1860 | $0.00 | 34,541.0000 | 103,700,000 | 5.69% | 0.00% |
| Feb. 8, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 1860 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 980 | $118.31 | 42,799.0000 | 103,700,000 | 2.24% | 0.00% |
| Feb. 8, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 1860 | $0.00 | 43,779.0000 | 103,700,000 | 4.44% | 0.00% |
| Feb. 8, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Restricted Stock Unit | 1329 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 700 | $118.31 | 1,998.0000 | 103,700,000 | 25.95% | 0.00% |
| Feb. 8, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 1329 | $0.00 | 2,698.0000 | 103,700,000 | 97.08% | 0.00% |
| Feb. 8, 2025 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 1860 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Gano Kyle | Chief Executive Officer | S | Common Stock | 980 | $118.39 | 137,658.0000 | 103,700,000 | 0.71% | 0.00% |
| Feb. 8, 2025 | Gano Kyle | Chief Executive Officer | M | Common Stock | 1860 | $0.00 | 138,638.0000 | 103,700,000 | 1.36% | 0.00% |
| Feb. 8, 2025 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 1727 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 911 | $118.25 | 41,679.0000 | 103,700,000 | 2.14% | 0.00% |
| Feb. 8, 2025 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 1727 | $0.00 | 42,590.0000 | 103,700,000 | 4.23% | 0.00% |
| Feb. 8, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 1860 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 980 | $118.22 | 33,253.0000 | 103,700,000 | 2.86% | 0.00% |
| Feb. 8, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1860 | $0.00 | 34,233.0000 | 103,700,000 | 5.75% | 0.00% |
| Feb. 8, 2025 | GORMAN KEVIN CHARLES | Director | M | Restricted Stock Unit | 4318 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | GORMAN KEVIN CHARLES | Director | S | Common Stock | 2274 | $118.37 | 519,074.0000 | 103,700,000 | 0.44% | 0.00% |
| Feb. 8, 2025 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 4318 | $0.00 | 521,348.0000 | 103,700,000 | 0.84% | 0.00% |
| Feb. 8, 2025 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1329 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 700 | $118.28 | 18,831.0000 | 103,700,000 | 3.58% | 0.00% |
| Jan. 31, 2025 | Gano Kyle | Chief Executive Officer | M | Restricted Stock Unit | 2927 | $0.00 | 2,927.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Restricted Stock Unit | 2436 | $0.00 | 2,437.0000 | 103,700,000 | 49.99% | 0.00% |
| Jan. 31, 2025 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1283 | $152.87 | 32,681.0000 | 103,700,000 | 3.78% | 0.00% |
| Jan. 31, 2025 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 2436 | $0.00 | 33,964.0000 | 103,700,000 | 7.73% | 0.00% |
| Jan. 31, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Restricted Stock Unit | 2294 | $0.00 | 2,294.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1207 | $152.94 | 41,919.0000 | 103,700,000 | 2.80% | 0.00% |
| Jan. 31, 2025 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 2294 | $0.00 | 43,126.0000 | 103,700,000 | 5.62% | 0.00% |
| Jan. 31, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Restriced Stock Unit | 2096 | $0.00 | 2,096.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1104 | $152.94 | 1,369.0000 | 103,700,000 | 44.64% | 0.00% |
| Jan. 31, 2025 | Boyer David W. | Chief Corp. Affairs Officer | M | Common Stock | 2096 | $0.00 | 2,473.0000 | 103,700,000 | 555.97% | 0.00% |
| Feb. 3, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Restricted Stock Unit | 1179 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Jan. 31, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Restriced Stock Unit | 801 | $0.00 | 801.0000 | 103,700,000 | 50.00% | 0.00% |
| Feb. 3, 2025 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 623 | $149.29 | 3,442.0000 | 103,700,000 | 15.33% | 0.00% |
| Feb. 3, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1179 | $0.00 | 4,065.0000 | 103,700,000 | 40.85% | 0.00% |
| Jan. 31, 2025 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 422 | $153.05 | 2,886.0000 | 103,700,000 | 12.76% | 0.00% |
| Jan. 31, 2025 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 1740 | $0.00 | 19,942.0000 | 103,700,000 | 9.56% | 0.00% |
| Jan. 31, 2025 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 916 | $152.89 | 19,026.0000 | 103,700,000 | 4.59% | 0.00% |
| Jan. 31, 2025 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 824 | $152.89 | 18,202.0000 | 103,700,000 | 4.33% | 0.00% |
| Jan. 31, 2025 | Cooke Julie | Chief Human Resources Officer | M | Restricted Stock Unit | 1740 | $0.00 | 1,741.0000 | 103,700,000 | 49.99% | 0.00% |
| Jan. 31, 2025 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 5141 | $0.00 | 519,737.0000 | 103,700,000 | 1.00% | 0.00% |
| Jan. 31, 2025 | GORMAN KEVIN CHARLES | Director | S | Common Stock | 2707 | $152.92 | 517,030.0000 | 103,700,000 | 0.52% | 0.00% |
| Jan. 31, 2025 | GORMAN KEVIN CHARLES | Director | M | Restricted Stock Unit | 5141 | $0.00 | 5,142.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 2769 | $0.00 | 33,830.0000 | 103,700,000 | 8.91% | 0.00% |
| Jan. 31, 2025 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1457 | $152.80 | 32,373.0000 | 103,700,000 | 4.31% | 0.00% |
| Jan. 31, 2025 | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 2769 | $0.00 | 2,769.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 238 | $0.00 | 15,687.0000 | 103,700,000 | 1.54% | 0.00% |
| Jan. 31, 2025 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 126 | $152.97 | 15,561.0000 | 103,700,000 | 0.80% | 0.00% |
| Jan. 31, 2025 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 238 | $0.00 | 238.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2373 | $0.00 | 42,113.0000 | 103,700,000 | 5.97% | 0.00% |
| Jan. 31, 2025 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1250 | $152.91 | 40,863.0000 | 103,700,000 | 2.97% | 0.00% |
| Jan. 31, 2025 | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2373 | $0.00 | 2,373.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | Gano Kyle | Chief Executive Officer | M | Common Stock | 2927 | $0.00 | 138,319.0000 | 103,700,000 | 2.16% | 0.00% |
| Jan. 31, 2025 | Gano Kyle | Chief Executive Officer | S | Common Stock | 1541 | $152.87 | 136,778.0000 | 103,700,000 | 1.11% | 0.00% |
| Jan. 31, 2025 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 801 | $0.00 | 3,308.0000 | 103,700,000 | 31.95% | 0.00% |
| Jan. 27, 2025 | GORMAN KEVIN CHARLES | Director | M | Non-Qualified Stock Option | 146105 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.14% |
| Jan. 27, 2025 | GORMAN KEVIN CHARLES | Director | M | Common Stock | 146105 | $32.99 | 660,701.0000 | 103,700,000 | 28.39% | 0.14% |
| Jan. 27, 2025 | GORMAN KEVIN CHARLES | Director | S | Common Stock | 146105 | $149.46 | 514,596.0000 | 103,700,000 | 22.11% | 0.14% |
| Jan. 15, 2025 | Gano Kyle | Chief Executive Officer | M | Common Stock | 60188 | $32.99 | 195,580.0000 | 103,700,000 | 44.45% | 0.06% |
| Jan. 15, 2025 | Gano Kyle | Chief Executive Officer | S | Common Stock | 60188 | $141.50 | 135,392.0000 | 103,700,000 | 30.77% | 0.06% |
| Jan. 15, 2025 | Gano Kyle | Chief Executive Officer | M | Non-Qualified Stock Option | 60188 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.06% |
| Jan. 15, 2025 | Gano Kyle | Chief Executive Officer | M | Incentive Stock Option | 4812 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Jan. 15, 2025 | Gano Kyle | Chief Executive Officer | M | Common Stock | 4812 | $32.99 | 140,204.0000 | 103,700,000 | 3.55% | 0.00% |
| Jan. 15, 2025 | Gano Kyle | Chief Executive Officer | S | Common Stock | 4812 | $141.50 | 135,392.0000 | 103,700,000 | 3.43% | 0.00% |
| Dec. 31, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 272 | $138.10 | 2,507.0000 | 104,300,000 | 9.79% | 0.00% |
| Dec. 31, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 272 | $79.02 | 2,779.0000 | 104,300,000 | 10.85% | 0.00% |
| Dec. 31, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 272 | $0.00 | 2,718.0000 | 104,300,000 | 9.10% | 0.00% |
| Dec. 17, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 1091 | $135.00 | 2,507.0000 | 104,300,000 | 30.32% | 0.00% |
| Dec. 17, 2024 | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 5487 | $0.00 | 5,487.0000 | 104,300,000 | 9999.99% | 0.01% |
| Dec. 17, 2024 | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 27770 | $0.00 | 27,770.0000 | 104,300,000 | 9999.99% | 0.03% |
| Dec. 17, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1091 | $79.02 | 3,598.0000 | 104,300,000 | 43.52% | 0.00% |
| Dec. 17, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 1091 | $0.00 | 2,990.0000 | 104,300,000 | 26.73% | 0.00% |
| Nov. 29, 2024 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 2331 | $126.29 | 15,449.0000 | 104,300,000 | 13.11% | 0.00% |
| Nov. 29, 2024 | Onyia Jude | Chief Scientific Officer | M | Common Stock | 4426 | $0.00 | 17,780.0000 | 104,300,000 | 33.14% | 0.00% |
| Nov. 29, 2024 | Onyia Jude | Chief Scientific Officer | M | Restricted Stock Unit | 4426 | $0.00 | 4,426.0000 | 104,300,000 | 50.00% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 971 | $102.90 | 31,060.0000 | 104,300,000 | 3.23% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 1 | $0.00 | 1,265.0000 | 104,300,000 | 0.08% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 971 | $0.00 | 0.0000 | 104,300,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 1233 | $0.00 | 0.0000 | 104,300,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 5140 | $0.00 | 0.0000 | 104,300,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1 | $79.02 | 31,061.0000 | 104,300,000 | 0.00% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1233 | $81.05 | 30,089.0000 | 104,300,000 | 4.27% | 0.00% |
| Nov. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 5140 | $77.81 | 28,856.0000 | 104,300,000 | 21.67% | 0.00% |
| Nov. 4, 2024 | SHERWIN STEPHEN A | Director | G | Common Stock | 2000 | $0.00 | 24,504.0000 | 104,300,000 | 7.55% | 0.00% |
| Nov. 1, 2024 | Gano Kyle | Chief Executive Officer | A | Stock Option | 13344 | $0.00 | 13,344.0000 | 104,300,000 | 9999.99% | 0.01% |
| Nov. 1, 2024 | Gano Kyle | Chief Executive Officer | A | Restricted Stock Unit | 2455 | $0.00 | 2,455.0000 | 104,300,000 | 9999.99% | 0.00% |
| Oct. 3, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1295 | $113.66 | 377.0000 | 104,300,000 | 77.45% | 0.00% |
| Sept. 13, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 3461 | $121.88 | 1,672.0000 | 101,000,000 | 67.43% | 0.00% |
| Aug. 15, 2024 | RASTETTER WILLIAM H | Director | S | Common Stock | 14250 | $146.69 | 37,491.0000 | 101,000,000 | 27.54% | 0.01% |
| Aug. 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 4100 | $150.08 | 2,507.0000 | 101,000,000 | 62.06% | 0.00% |
| Aug. 13, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 14100 | $150.38 | 31,528.0000 | 101,000,000 | 30.90% | 0.01% |
| Aug. 13, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 14100 | $73.60 | 45,628.0000 | 101,000,000 | 44.72% | 0.01% |
| Aug. 13, 2024 | LYONS GARY A | Director | M | Non-Qualified Stock Option | 11570 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Aug. 13, 2024 | LYONS GARY A | Director | S | Common Stock | 11570 | $150.43 | 119,047.0000 | 101,000,000 | 8.86% | 0.01% |
| Aug. 13, 2024 | LYONS GARY A | Director | M | Common Stock | 11570 | $42.76 | 130,617.0000 | 101,000,000 | 9.72% | 0.01% |
| Aug. 13, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Non-Qualified Stock Option | 14100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Aug. 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 3043 | $103.52 | 9,650.0000 | 101,000,000 | 46.06% | 0.00% |
| Aug. 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 3043 | $0.00 | 22,049.0000 | 101,000,000 | 12.13% | 0.00% |
| Aug. 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 3043 | $150.13 | 6,607.0000 | 101,000,000 | 31.53% | 0.00% |
| Aug. 6, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 273 | $147.70 | 6,607.0000 | 101,000,000 | 3.97% | 0.00% |
| Aug. 6, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 273 | $79.02 | 6,880.0000 | 101,000,000 | 4.13% | 0.00% |
| Aug. 6, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 273 | $0.00 | 4,081.0000 | 101,000,000 | 6.27% | 0.00% |
| Aug. 1, 2024 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 2996 | $154.01 | 39,740.0000 | 101,000,000 | 7.01% | 0.00% |
| Aug. 1, 2024 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2996 | $79.02 | 42,736.0000 | 101,000,000 | 7.54% | 0.00% |
| Aug. 1, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 12632 | $153.26 | 18,202.0000 | 101,000,000 | 40.97% | 0.01% |
| Aug. 1, 2024 | Cooke Julie | Chief Human Resources Officer | M | Non-Qualified Stock Option | 12632 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Aug. 1, 2024 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 12632 | $61.82 | 30,834.0000 | 101,000,000 | 69.40% | 0.01% |
| Aug. 1, 2024 | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 2996 | $0.00 | 43,372.0000 | 101,000,000 | 6.46% | 0.00% |
| July 16, 2024 | LYONS GARY A | Director | M | Common Stock | 930 | $42.76 | 119,977.0000 | 101,000,000 | 0.78% | 0.00% |
| July 16, 2024 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 900 | $61.82 | 19,102.0000 | 101,000,000 | 4.94% | 0.00% |
| July 16, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 900 | $150.04 | 18,202.0000 | 101,000,000 | 4.71% | 0.00% |
| July 16, 2024 | Cooke Julie | Chief Human Resources Officer | M | Non-Qualified Stock Option | 900 | $0.00 | 12,632.0000 | 101,000,000 | 6.65% | 0.00% |
| July 16, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 400 | $103.52 | 7,907.0000 | 101,000,000 | 5.33% | 0.00% |
| July 16, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 400 | $150.10 | 7,507.0000 | 101,000,000 | 5.06% | 0.00% |
| July 16, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1557 | $103.52 | 9,064.0000 | 101,000,000 | 20.74% | 0.00% |
| July 16, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 1557 | $150.00 | 7,507.0000 | 101,000,000 | 17.18% | 0.00% |
| July 16, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 900 | $150.04 | 6,607.0000 | 101,000,000 | 11.99% | 0.00% |
| July 16, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 400 | $0.00 | 26,649.0000 | 101,000,000 | 1.48% | 0.00% |
| July 16, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 1557 | $0.00 | 25,092.0000 | 101,000,000 | 5.84% | 0.00% |
| July 16, 2024 | LYONS GARY A | Director | S | Common Stock | 930 | $150.03 | 119,047.0000 | 101,000,000 | 0.78% | 0.00% |
| July 16, 2024 | LYONS GARY A | Director | M | Non-Qualified Stock Option | 930 | $0.00 | 11,570.0000 | 101,000,000 | 7.44% | 0.00% |
| July 16, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 900 | $73.60 | 32,428.0000 | 101,000,000 | 2.85% | 0.00% |
| July 16, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 900 | $150.04 | 31,528.0000 | 101,000,000 | 2.78% | 0.00% |
| July 16, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Non-Qualified Stock Option | 900 | $0.00 | 14,100.0000 | 101,000,000 | 6.00% | 0.00% |
| July 16, 2024 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 7004 | $79.02 | 46,744.0000 | 101,000,000 | 17.62% | 0.01% |
| July 16, 2024 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 7004 | $150.00 | 39,740.0000 | 101,000,000 | 14.98% | 0.01% |
| July 16, 2024 | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 7004 | $0.00 | 46,368.0000 | 101,000,000 | 13.12% | 0.01% |
| July 1, 2024 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 10000 | $61.82 | 28,202.0000 | 101,000,000 | 54.94% | 0.01% |
| July 1, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 272 | $0.00 | 4,354.0000 | 101,000,000 | 5.88% | 0.00% |
| July 1, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 272 | $138.11 | 7,507.0000 | 101,000,000 | 3.50% | 0.00% |
| July 1, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 272 | $79.02 | 7,779.0000 | 101,000,000 | 3.62% | 0.00% |
| July 1, 2024 | Cooke Julie | Chief Human Resources Officer | M | Non-Qualified Stock Option | 10000 | $0.00 | 13,532.0000 | 101,000,000 | 42.50% | 0.01% |
| July 1, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 10000 | $140.19 | 18,202.0000 | 101,000,000 | 35.46% | 0.01% |
| May 31, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 273 | $0.00 | 4,626.0000 | 101,000,000 | 5.57% | 0.00% |
| May 31, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 273 | $136.55 | 7,507.0000 | 101,000,000 | 3.51% | 0.00% |
| May 31, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 273 | $79.02 | 7,780.0000 | 101,000,000 | 3.64% | 0.00% |
| May 29, 2024 | SHERWIN STEPHEN A | Director | S | Common Stock | 15000 | $133.47 | 26,504.0000 | 101,000,000 | 36.14% | 0.01% |
| May 29, 2024 | SHERWIN STEPHEN A | Director | M | Common Stock | 15000 | $47.89 | 41,504.0000 | 101,000,000 | 56.60% | 0.01% |
| May 29, 2024 | SHERWIN STEPHEN A | Director | M | Common Stock | 25000 | $42.76 | 51,504.0000 | 101,000,000 | 94.33% | 0.02% |
| May 29, 2024 | SHERWIN STEPHEN A | Director | S | Common Stock | 25000 | $133.46 | 26,504.0000 | 101,000,000 | 48.54% | 0.02% |
| May 29, 2024 | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 15000 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| May 29, 2024 | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 25000 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| May 22, 2024 | Norwalk Leslie V | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | Norwalk Leslie V | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | MORROW GEORGE J | Director | A | Restricted Stock Unit | 2869 | $0.00 | 2,869.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | Mercier Johanna | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | Sharp Shalini | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | Sharp Shalini | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | POON CHRISTINE A | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | POON CHRISTINE A | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | RASTETTER WILLIAM H | Director | A | Restricted Stock Unit | 2869 | $0.00 | 2,869.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | SHERWIN STEPHEN A | Director | A | Restricted Stock Unit | 2869 | $0.00 | 2,869.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | POPS RICHARD F | Director | A | Restricted Stock Unit | 2869 | $0.00 | 2,869.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | LYONS GARY A | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | Mercier Johanna | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | LYONS GARY A | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | POPS RICHARD F | Director | S | Common Stock | 2100 | $141.84 | 31,611.0000 | 101,000,000 | 6.23% | 0.00% |
| May 17, 2024 | Norwalk Leslie V | Director | S | Common Stock | 1106 | $141.82 | 994.0000 | 101,000,000 | 52.67% | 0.00% |
| May 17, 2024 | Norwalk Leslie V | Director | M | Common Stock | 2100 | $0.00 | 2,100.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | MORROW GEORGE J | Director | M | Restricted Stock Unit | 4199 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | MORROW GEORGE J | Director | M | Common Stock | 4199 | $0.00 | 4,199.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | POPS RICHARD F | Director | M | Restricted Stock Unit | 4199 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | POPS RICHARD F | Director | M | Common Stock | 4199 | $0.00 | 33,711.0000 | 101,000,000 | 14.23% | 0.00% |
| May 17, 2024 | Sharp Shalini | Director | M | Restricted Stock Unit | 2100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | Sharp Shalini | Director | S | Common Stock | 1106 | $141.90 | 994.0000 | 101,000,000 | 52.67% | 0.00% |
| May 17, 2024 | Sharp Shalini | Director | M | Common Stock | 2100 | $0.00 | 2,100.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | Mercier Johanna | Director | M | Restricted Stock Unit | 2100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | Mercier Johanna | Director | M | Common Stock | 2100 | $0.00 | 2,100.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | SHERWIN STEPHEN A | Director | M | Restricted Stock Unit | 4199 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | SHERWIN STEPHEN A | Director | M | Common Stock | 4199 | $0.00 | 26,504.0000 | 101,000,000 | 18.83% | 0.00% |
| May 17, 2024 | LYONS GARY A | Director | M | Restricted Stock Unit | 2100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | LYONS GARY A | Director | M | Common Stock | 2100 | $0.00 | 119,047.0000 | 101,000,000 | 1.80% | 0.00% |
| May 17, 2024 | Norwalk Leslie V | Director | M | Restricted Stock Unit | 2100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 14, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 15000 | $73.60 | 46,528.0000 | 101,000,000 | 47.58% | 0.01% |
| May 14, 2024 | LYONS GARY A | Director | M | Non-Qualified Stock Option | 12500 | $42.76 | 12,500.0000 | 101,000,000 | 50.00% | 0.01% |
| May 14, 2024 | LYONS GARY A | Director | S | Common Stock | 12500 | $135.63 | 116,947.0000 | 101,000,000 | 9.66% | 0.01% |
| May 14, 2024 | LYONS GARY A | Director | M | Common Stock | 12500 | $42.76 | 129,447.0000 | 101,000,000 | 10.69% | 0.01% |
| May 15, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Common Stock | 15000 | $73.60 | 46,528.0000 | 101,000,000 | 47.58% | 0.01% |
| May 14, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Non-Qualified Stock Option | 15000 | $73.60 | 30,000.0000 | 101,000,000 | 33.33% | 0.01% |
| May 15, 2024 | ABERNETHY MATT | Chief Financial Officer | M | Non-Qualified Stock Option | 15000 | $73.60 | 15,000.0000 | 101,000,000 | 50.00% | 0.01% |
| May 15, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 15000 | $140.24 | 31,528.0000 | 101,000,000 | 32.24% | 0.01% |
| May 14, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 15000 | $135.66 | 31,528.0000 | 101,000,000 | 32.24% | 0.01% |
| May 6, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 273 | $79.02 | 4,899.0000 | 101,000,000 | 5.28% | 0.00% |
| May 6, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 273 | $79.02 | 7,780.0000 | 101,000,000 | 3.64% | 0.00% |
| May 6, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 273 | $140.55 | 7,507.0000 | 101,000,000 | 3.51% | 0.00% |
| April 15, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Non-Qualified Stock Option | 7231 | $81.49 | 26,292.0000 | 101,000,000 | 21.57% | 0.01% |
| April 15, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Non-Qualified Stock Option | 12587 | $81.05 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| April 15, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 7231 | $81.49 | 48,009.0000 | 101,000,000 | 17.73% | 0.01% |
| April 15, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 7231 | $133.36 | 40,778.0000 | 101,000,000 | 15.06% | 0.01% |
| April 15, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 12587 | $81.05 | 53,365.0000 | 101,000,000 | 30.87% | 0.01% |
| April 15, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 12587 | $133.36 | 40,778.0000 | 101,000,000 | 23.59% | 0.01% |
| April 1, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 272 | $79.02 | 7,779.0000 | 101,000,000 | 3.62% | 0.00% |
| April 1, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 272 | $137.30 | 7,507.0000 | 101,000,000 | 3.50% | 0.00% |
| April 1, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 272 | $79.02 | 5,172.0000 | 101,000,000 | 5.00% | 0.00% |
| March 21, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 5000 | $145.06 | 7,507.0000 | 101,000,000 | 39.98% | 0.00% |
| March 21, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 5000 | $103.52 | 27,049.0000 | 101,000,000 | 15.60% | 0.00% |
| March 21, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 5000 | $103.52 | 12,507.0000 | 101,000,000 | 66.60% | 0.00% |
| March 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 3000 | $106.02 | 4,367.0000 | 101,000,000 | 40.72% | 0.00% |
| March 14, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 69521 | $139.38 | 40,778.0000 | 101,000,000 | 63.03% | 0.07% |
| March 14, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 69521 | $81.05 | 110,299.0000 | 101,000,000 | 170.49% | 0.07% |
| March 14, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 5479 | $139.38 | 40,778.0000 | 101,000,000 | 11.84% | 0.01% |
| March 14, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 5479 | $79.02 | 46,257.0000 | 101,000,000 | 13.44% | 0.01% |
| March 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 3000 | $106.02 | 10,507.0000 | 101,000,000 | 39.96% | 0.00% |
| March 14, 2024 | MORROW GEORGE J | Director | M | Common Stock | 20000 | $39.79 | 20,000.0000 | 101,000,000 | 9999.99% | 0.02% |
| March 14, 2024 | MORROW GEORGE J | Director | S | Common Stock | 20000 | $139.42 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| March 14, 2024 | MORROW GEORGE J | Director | M | Common Stock | 20000 | $39.79 | 20,000.0000 | 101,000,000 | 9999.99% | 0.02% |
| March 14, 2024 | MORROW GEORGE J | Director | S | Common Stock | 20000 | $139.41 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| March 14, 2024 | MORROW GEORGE J | Director | M | Non-Qualified Stock Option | 20000 | $39.79 | 20,000.0000 | 101,000,000 | 50.00% | 0.02% |
| March 14, 2024 | MORROW GEORGE J | Director | M | Non-Qualified Stock Option | 20000 | $39.79 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| March 13, 2024 | POPS RICHARD F | Director | M | Common Stock | 23200 | $42.76 | 52,712.0000 | 101,000,000 | 78.61% | 0.02% |
| March 13, 2024 | POPS RICHARD F | Director | S | Common Stock | 23200 | $140.33 | 29,512.0000 | 101,000,000 | 44.01% | 0.02% |
| March 13, 2024 | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 23200 | $42.76 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| March 14, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Non-Qualified Stock Option | 69521 | $81.05 | 12,587.0000 | 101,000,000 | 84.67% | 0.07% |
| March 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 3000 | $140.14 | 7,507.0000 | 101,000,000 | 28.55% | 0.00% |
| March 14, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Non-Qualified Stock Option | 5479 | $79.02 | 33,881.0000 | 101,000,000 | 13.92% | 0.01% |
| March 8, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 1800 | $106.02 | 7,567.0000 | 101,000,000 | 19.22% | 0.00% |
| March 11, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 200 | $140.00 | 7,507.0000 | 101,000,000 | 2.60% | 0.00% |
| March 11, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 200 | $106.02 | 7,707.0000 | 101,000,000 | 2.66% | 0.00% |
| March 8, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 1800 | $140.03 | 7,507.0000 | 101,000,000 | 19.34% | 0.00% |
| March 8, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1800 | $106.02 | 9,307.0000 | 101,000,000 | 23.98% | 0.00% |
| March 11, 2024 | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 100 | $42.76 | 23,200.0000 | 101,000,000 | 0.43% | 0.00% |
| March 8, 2024 | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 1700 | $42.76 | 23,300.0000 | 101,000,000 | 6.80% | 0.00% |
| March 11, 2024 | POPS RICHARD F | Director | S | Common Stock | 100 | $140.00 | 29,512.0000 | 101,000,000 | 0.34% | 0.00% |
| March 11, 2024 | POPS RICHARD F | Director | M | Common Stock | 100 | $42.76 | 29,612.0000 | 101,000,000 | 0.34% | 0.00% |
| March 8, 2024 | POPS RICHARD F | Director | S | Common Stock | 1700 | $140.05 | 29,512.0000 | 101,000,000 | 5.45% | 0.00% |
| March 8, 2024 | POPS RICHARD F | Director | M | Common Stock | 1700 | $42.76 | 31,212.0000 | 101,000,000 | 5.76% | 0.00% |
| March 11, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 200 | $106.02 | 7,367.0000 | 101,000,000 | 2.64% | 0.00% |
| Feb. 28, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Non-Qualified Stock Option | 21857 | $79.02 | 39,360.0000 | 101,000,000 | 35.70% | 0.02% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 2500 | $79.02 | 10,007.0000 | 101,000,000 | 33.30% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 2500 | $135.64 | 7,507.0000 | 101,000,000 | 24.98% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 2500 | $79.02 | 10,007.0000 | 101,000,000 | 33.30% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 2500 | $134.62 | 7,507.0000 | 101,000,000 | 24.98% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 1544 | $79.02 | 9,051.0000 | 101,000,000 | 20.57% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 1544 | $136.00 | 7,507.0000 | 101,000,000 | 17.06% | 0.00% |
| Feb. 29, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Common Stock | 273 | $79.02 | 7,780.0000 | 101,000,000 | 3.64% | 0.00% |
| Feb. 29, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 273 | $135.51 | 7,507.0000 | 101,000,000 | 3.51% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 2500 | $79.02 | 9,761.0000 | 101,000,000 | 20.39% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 2500 | $79.02 | 7,261.0000 | 101,000,000 | 25.61% | 0.00% |
| Feb. 28, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 1544 | $79.02 | 5,717.0000 | 101,000,000 | 21.26% | 0.00% |
| Feb. 29, 2024 | Delaet Ingrid | Chief Regulatory Officer | M | Non-Qualified Stock Option | 273 | $79.02 | 5,444.0000 | 101,000,000 | 4.78% | 0.00% |
| Feb. 28, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 53143 | $43.24 | 93,759.0000 | 101,000,000 | 130.84% | 0.05% |
| Feb. 28, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 53143 | $134.69 | 40,616.0000 | 101,000,000 | 56.68% | 0.05% |
| Feb. 28, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 21857 | $79.02 | 62,473.0000 | 101,000,000 | 53.81% | 0.02% |
| Feb. 28, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 21857 | $134.69 | 40,616.0000 | 101,000,000 | 34.99% | 0.02% |
| Feb. 28, 2024 | BENEVICH ERIC | Chief Commercial Officer | M | Non-Qualified Stock Option | 53143 | $43.24 | 0.0000 | 101,000,000 | 100.00% | 0.05% |
| Feb. 27, 2024 | Norwalk Leslie V | Director | M | Common Stock | 8000 | $84.95 | 8,000.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2024 | Norwalk Leslie V | Director | S | Common Stock | 8000 | $135.67 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Feb. 27, 2024 | Norwalk Leslie V | Director | M | Non-Qualified Stock Option | 8000 | $84.95 | 1,724.0000 | 101,000,000 | 82.27% | 0.01% |
| Feb. 20, 2024 | POPS RICHARD F | Director | S | Common Stock | 15000 | $132.47 | 29,512.0000 | 101,000,000 | 33.70% | 0.01% |
| Feb. 20, 2024 | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 15000 | $12.98 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Feb. 20, 2024 | POPS RICHARD F | Director | M | Common Stock | 15000 | $12.98 | 44,512.0000 | 101,000,000 | 50.83% | 0.01% |
| Feb. 13, 2024 | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 4483 | $0.00 | 4,483.0000 | 101,000,000 | 9999.99% | 0.00% |
| Feb. 13, 2024 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 1432 | $132.94 | 13,128.0000 | 101,000,000 | 9.84% | 0.00% |
| Feb. 13, 2024 | Onyia Jude | Chief Scientific Officer | A | Stock Option | 54069 | $0.00 | 54,069.0000 | 101,000,000 | 9999.99% | 0.05% |
| Feb. 13, 2024 | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 10760 | $0.00 | 10,760.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1098 | $132.99 | 39,740.0000 | 101,000,000 | 2.69% | 0.00% |
| Feb. 13, 2024 | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 40552 | $0.00 | 40,552.0000 | 101,000,000 | 9999.99% | 0.04% |
| Feb. 13, 2024 | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 8070 | $0.00 | 8,070.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 2832 | $133.02 | 514,596.0000 | 101,000,000 | 0.55% | 0.00% |
| Feb. 13, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | A | Stock Option | 112644 | $0.00 | 112,644.0000 | 101,000,000 | 9999.99% | 0.11% |
| Feb. 13, 2024 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1114 | $132.96 | 23,716.0000 | 101,000,000 | 4.49% | 0.00% |
| Feb. 13, 2024 | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 22529 | $0.00 | 22,529.0000 | 101,000,000 | 9999.99% | 0.02% |
| Feb. 13, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | A | Restricted Stock Unit | 22415 | $0.00 | 22,415.0000 | 101,000,000 | 9999.99% | 0.02% |
| Feb. 13, 2024 | Gano Kyle | Chief Business Development Off | S | Common Stock | 1352 | $132.89 | 135,166.0000 | 101,000,000 | 0.99% | 0.00% |
| Feb. 13, 2024 | Gano Kyle | Chief Business Development Off | A | Stock Option | 45058 | $0.00 | 45,058.0000 | 101,000,000 | 9999.99% | 0.04% |
| Feb. 13, 2024 | Gano Kyle | Chief Business Development Off | A | Restricted Stock Unit | 8966 | $0.00 | 8,966.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 716 | $133.03 | 7,507.0000 | 101,000,000 | 8.71% | 0.00% |
| Feb. 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | A | Stock Option | 28161 | $0.00 | 28,161.0000 | 101,000,000 | 9999.99% | 0.03% |
| Feb. 13, 2024 | Delaet Ingrid | Chief Regulatory Officer | A | Restricted Stock Unit | 5604 | $0.00 | 5,604.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 796 | $133.04 | 17,976.0000 | 101,000,000 | 4.24% | 0.00% |
| Feb. 13, 2024 | Cooke Julie | Chief Human Resources Officer | A | Stock Option | 28161 | $0.00 | 28,161.0000 | 101,000,000 | 9999.99% | 0.03% |
| Feb. 13, 2024 | Cooke Julie | Chief Human Resources Officer | A | Restricted Stock Unit | 5604 | $0.00 | 5,604.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 955 | $133.10 | 5,751.0000 | 101,000,000 | 14.24% | 0.00% |
| Feb. 13, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 856 | $133.05 | 4,895.0000 | 101,000,000 | 14.88% | 0.00% |
| Feb. 13, 2024 | Boyer David W. | Chief Corp. Affairs Officer | A | Stock Option | 30977 | $0.00 | 30,977.0000 | 101,000,000 | 9999.99% | 0.03% |
| Feb. 13, 2024 | Boyer David W. | Chief Corp. Affairs Officer | A | Restricted Stock Unit | 6165 | $0.00 | 6,165.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1098 | $133.01 | 40,616.0000 | 101,000,000 | 2.63% | 0.00% |
| Feb. 13, 2024 | BENEVICH ERIC | Chief Commercial Officer | A | Stock Option | 39426 | $0.00 | 39,426.0000 | 101,000,000 | 9999.99% | 0.04% |
| Feb. 13, 2024 | BENEVICH ERIC | Chief Commercial Officer | A | Restricted Stock Unit | 7846 | $0.00 | 7,846.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1352 | $132.85 | 31,528.0000 | 101,000,000 | 4.11% | 0.00% |
| Feb. 13, 2024 | ABERNETHY MATT | Chief Financial Officer | A | Stock Option | 45058 | $0.00 | 45,058.0000 | 101,000,000 | 9999.99% | 0.04% |
| Feb. 13, 2024 | ABERNETHY MATT | Chief Financial Officer | A | Restricted Stock Unit | 8966 | $0.00 | 8,966.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 13, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Common Stock | 2778 | $35.99 | 509,740.0000 | 101,000,000 | 0.55% | 0.00% |
| Feb. 13, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Incentive Stock Option | 2312 | $43.24 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| Feb. 13, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Common Stock | 2312 | $43.24 | 512,052.0000 | 101,000,000 | 0.45% | 0.00% |
| Feb. 13, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Incentive Stock Option | 2778 | $35.99 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| Feb. 8, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 700 | $134.19 | 5,523.0000 | 101,000,000 | 11.25% | 0.00% |
| Feb. 8, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 628 | $136.78 | 4,895.0000 | 101,000,000 | 11.37% | 0.00% |
| Feb. 6, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 640 | $142.17 | 17,838.0000 | 101,000,000 | 3.46% | 0.00% |
| Feb. 6, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 575 | $141.96 | 17,263.0000 | 101,000,000 | 3.22% | 0.00% |
| Feb. 8, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 700 | $134.23 | 17,892.0000 | 101,000,000 | 3.77% | 0.00% |
| Feb. 8, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 629 | $136.78 | 17,263.0000 | 101,000,000 | 3.52% | 0.00% |
| Feb. 6, 2024 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1121 | $142.24 | 21,837.0000 | 101,000,000 | 4.88% | 0.00% |
| Feb. 8, 2024 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 980 | $134.21 | 22,717.0000 | 101,000,000 | 4.14% | 0.00% |
| Feb. 6, 2024 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1041 | $142.17 | 37,939.0000 | 101,000,000 | 2.67% | 0.00% |
| Feb. 8, 2024 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 911 | $134.24 | 38,755.0000 | 101,000,000 | 2.30% | 0.00% |
| Feb. 6, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 3040 | $142.18 | 504,919.0000 | 101,000,000 | 0.60% | 0.00% |
| Feb. 8, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 2274 | $134.15 | 506,962.0000 | 101,000,000 | 0.45% | 0.00% |
| Feb. 6, 2024 | Gano Kyle | Chief Business Development Off | S | Common Stock | 1600 | $142.20 | 133,072.0000 | 101,000,000 | 1.19% | 0.00% |
| Feb. 8, 2024 | Gano Kyle | Chief Business Development Off | S | Common Stock | 980 | $134.20 | 133,952.0000 | 101,000,000 | 0.73% | 0.00% |
| Feb. 6, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1280 | $142.12 | 38,751.0000 | 101,000,000 | 3.20% | 0.00% |
| Feb. 6, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1280 | $142.19 | 29,434.0000 | 101,000,000 | 4.17% | 0.00% |
| Feb. 8, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 980 | $134.19 | 39,631.0000 | 101,000,000 | 2.41% | 0.00% |
| Feb. 8, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 980 | $134.21 | 30,314.0000 | 101,000,000 | 3.13% | 0.00% |
| Feb. 6, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 240 | $141.96 | 5,110.0000 | 101,000,000 | 4.49% | 0.00% |
| Feb. 6, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 216 | $141.96 | 4,894.0000 | 101,000,000 | 4.23% | 0.00% |
| Feb. 1, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 623 | $139.77 | 6,865.0000 | 101,000,000 | 8.32% | 0.00% |
| Jan. 31, 2024 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1457 | $140.79 | 20,832.0000 | 101,000,000 | 6.54% | 0.00% |
| Jan. 31, 2024 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 126 | $141.94 | 11,843.0000 | 101,000,000 | 1.05% | 0.00% |
| Jan. 31, 2024 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1250 | $140.65 | 37,005.0000 | 101,000,000 | 3.27% | 0.00% |
| Jan. 31, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 2707 | $140.69 | 502,188.0000 | 101,000,000 | 0.54% | 0.00% |
| Jan. 31, 2024 | Gano Kyle | Chief Business Development Off | S | Common Stock | 1541 | $140.70 | 131,635.0000 | 101,000,000 | 1.16% | 0.00% |
| Jan. 31, 2024 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 422 | $141.94 | 6,309.0000 | 101,000,000 | 6.27% | 0.00% |
| Jan. 31, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 916 | $140.70 | 18,087.0000 | 101,000,000 | 4.82% | 0.00% |
| Jan. 31, 2024 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 824 | $141.94 | 17,263.0000 | 101,000,000 | 4.56% | 0.00% |
| Jan. 31, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1104 | $140.87 | 5,886.0000 | 101,000,000 | 15.79% | 0.00% |
| Jan. 31, 2024 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 992 | $140.72 | 4,894.0000 | 101,000,000 | 16.85% | 0.00% |
| Jan. 31, 2024 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1207 | $140.78 | 37,601.0000 | 101,000,000 | 3.11% | 0.00% |
| Jan. 31, 2024 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1283 | $140.72 | 28,284.0000 | 101,000,000 | 4.34% | 0.00% |
| Jan. 22, 2024 | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 10000 | $79.02 | 53,372.0000 | 101,000,000 | 15.78% | 0.01% |
| Jan. 22, 2024 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 10000 | $79.02 | 45,882.0000 | 101,000,000 | 27.87% | 0.01% |
| Jan. 22, 2024 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 10000 | $139.86 | 35,882.0000 | 101,000,000 | 21.80% | 0.01% |
| Jan. 9, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Common Stock | 62023 | $19.59 | 561,777.0000 | 101,000,000 | 12.41% | 0.06% |
| Jan. 9, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 62023 | $134.01 | 499,754.0000 | 101,000,000 | 11.04% | 0.06% |
| Jan. 9, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Non-Qualified Stock Option | 62023 | $19.59 | 0.0000 | 101,000,000 | 100.00% | 0.06% |
| Jan. 8, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Non-Qualified Stock Option | 105835 | $19.59 | 62,023.0000 | 101,000,000 | 63.05% | 0.10% |
| Jan. 8, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | M | Common Stock | 105835 | $19.59 | 605,589.0000 | 101,000,000 | 21.18% | 0.10% |
| Jan. 8, 2024 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 105835 | $132.44 | 499,754.0000 | 101,000,000 | 17.48% | 0.10% |
| Jan. 2, 2024 | RASTETTER WILLIAM H | Director | S | Common Stock | 11044 | $131.47 | 51,741.0000 | 101,000,000 | 17.59% | 0.01% |
| Jan. 2, 2024 | Gano Kyle | Chief Business Development Off | M | Common Stock | 68884 | $19.59 | 199,134.0000 | 101,000,000 | 52.89% | 0.07% |
| Jan. 2, 2024 | Gano Kyle | Chief Business Development Off | S | Common Stock | 68884 | $131.47 | 130,250.0000 | 101,000,000 | 34.59% | 0.07% |
| Jan. 2, 2024 | Gano Kyle | Chief Business Development Off | M | Common Stock | 6116 | $19.59 | 136,366.0000 | 101,000,000 | 4.70% | 0.01% |
| Jan. 2, 2024 | Gano Kyle | Chief Business Development Off | S | Common Stock | 6116 | $131.44 | 130,250.0000 | 101,000,000 | 4.48% | 0.01% |
| Jan. 2, 2024 | Gano Kyle | Chief Business Development Off | M | Non-Qualified Stock Option | 68884 | $19.59 | 0.0000 | 101,000,000 | 100.00% | 0.07% |
| Jan. 2, 2024 | Gano Kyle | Chief Business Development Off | M | Incentive Stock Option | 6116 | $19.59 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Jan. 2, 2024 | RASTETTER WILLIAM H | Director | M | Common Stock | 20000 | $12.98 | 62,785.0000 | 101,000,000 | 46.75% | 0.02% |
| Jan. 2, 2024 | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 20000 | $12.98 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| Dec. 22, 2023 | Cooke Julie | Chief Human Resources Officer | M | Non-Qualified Stock Option | 14000 | $81.05 | 8,129.0000 | 98,900,000 | 63.27% | 0.01% |
| Dec. 22, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 10000 | $126.74 | 19,521.0000 | 98,900,000 | 33.87% | 0.01% |
| Dec. 22, 2023 | LYONS GARY A | Director | S | Common Stock | 10000 | $130.04 | 193,697.0000 | 98,900,000 | 4.91% | 0.01% |
| Dec. 22, 2023 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 14000 | $81.05 | 31,263.0000 | 98,900,000 | 81.10% | 0.01% |
| Dec. 22, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 14000 | $129.99 | 17,263.0000 | 98,900,000 | 44.78% | 0.01% |
| Dec. 22, 2023 | Cooke Julie | Chief Human Resources Officer | M | Common Stock | 10000 | $61.82 | 27,263.0000 | 98,900,000 | 57.93% | 0.01% |
| Dec. 22, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 10000 | $126.79 | 17,263.0000 | 98,900,000 | 36.68% | 0.01% |
| Dec. 22, 2023 | Cooke Julie | Chief Human Resources Officer | M | Non-Qualified Stock Option | 10000 | $61.82 | 23,532.0000 | 98,900,000 | 29.82% | 0.01% |
| Dec. 12, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 6947 | $120.31 | 29,521.0000 | 98,900,000 | 19.05% | 0.01% |
| Dec. 12, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 6978 | $81.05 | 36,499.0000 | 98,900,000 | 23.64% | 0.01% |
| Dec. 12, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 6978 | $120.30 | 29,521.0000 | 98,900,000 | 19.12% | 0.01% |
| Dec. 12, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 6947 | $81.05 | 36,468.0000 | 98,900,000 | 23.53% | 0.01% |
| Dec. 12, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 6978 | $81.05 | 46,387.0000 | 98,900,000 | 13.08% | 0.01% |
| Dec. 12, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 6947 | $81.05 | 39,440.0000 | 98,900,000 | 14.98% | 0.01% |
| Dec. 8, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 100 | $81.05 | 53,365.0000 | 98,900,000 | 0.19% | 0.00% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 38722 | $77.81 | 68,243.0000 | 98,900,000 | 131.17% | 0.04% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 38722 | $120.37 | 29,521.0000 | 98,900,000 | 56.74% | 0.04% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 12742 | $77.81 | 42,263.0000 | 98,900,000 | 43.16% | 0.01% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 12742 | $120.37 | 29,521.0000 | 98,900,000 | 30.15% | 0.01% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 14140 | $79.02 | 43,661.0000 | 98,900,000 | 47.90% | 0.01% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 14140 | $120.37 | 29,521.0000 | 98,900,000 | 32.39% | 0.01% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 11775 | $81.05 | 41,296.0000 | 98,900,000 | 39.89% | 0.01% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 11775 | $120.37 | 29,521.0000 | 98,900,000 | 28.51% | 0.01% |
| Dec. 8, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 200 | $81.05 | 29,721.0000 | 98,900,000 | 0.68% | 0.00% |
| Dec. 8, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 200 | $120.16 | 29,521.0000 | 98,900,000 | 0.67% | 0.00% |
| Dec. 8, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 100 | $81.05 | 29,621.0000 | 98,900,000 | 0.34% | 0.00% |
| Dec. 8, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 100 | $120.00 | 29,521.0000 | 98,900,000 | 0.34% | 0.00% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 38722 | $77.81 | 12,742.0000 | 98,900,000 | 75.24% | 0.04% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 12742 | $77.81 | 0.0000 | 98,900,000 | 100.00% | 0.01% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 14140 | $79.02 | 60,005.0000 | 98,900,000 | 19.07% | 0.01% |
| Dec. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 11775 | $81.05 | 53,665.0000 | 98,900,000 | 17.99% | 0.01% |
| Dec. 8, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 200 | $81.05 | 53,465.0000 | 98,900,000 | 0.37% | 0.00% |
| Dec. 6, 2023 | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 20830 | $43.24 | 56,712.0000 | 98,900,000 | 58.05% | 0.02% |
| Dec. 6, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 8396 | $77.81 | 37,917.0000 | 98,900,000 | 28.44% | 0.01% |
| Dec. 6, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 8396 | $120.03 | 29,521.0000 | 98,900,000 | 22.14% | 0.01% |
| Dec. 6, 2023 | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 8396 | $77.81 | 51,464.0000 | 98,900,000 | 14.03% | 0.01% |
| Dec. 6, 2023 | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 20830 | $43.24 | 4,376.0000 | 98,900,000 | 82.64% | 0.02% |
| Dec. 6, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 20830 | $119.86 | 35,882.0000 | 98,900,000 | 36.73% | 0.02% |
| Dec. 1, 2023 | LYONS GARY A | Director | M | Common Stock | 5000 | $12.98 | 208,697.0000 | 98,900,000 | 2.45% | 0.01% |
| Dec. 1, 2023 | LYONS GARY A | Director | S | Common Stock | 5000 | $116.77 | 203,697.0000 | 98,900,000 | 2.40% | 0.01% |
| Dec. 1, 2023 | LYONS GARY A | Director | M | Non-Qualified Stock Option | 5000 | $12.98 | 0.0000 | 98,900,000 | 100.00% | 0.01% |
| Nov. 29, 2023 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 2331 | $113.57 | 11,732.0000 | 98,900,000 | 16.58% | 0.00% |
| Nov. 27, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 10919 | $112.27 | 35,882.0000 | 98,900,000 | 23.33% | 0.01% |
| Nov. 16, 2023 | SHERWIN STEPHEN A | Director | G | Common Stock | 2750 | $0.00 | 22,305.0000 | 98,900,000 | 10.98% | 0.00% |
| Oct. 2, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1437 | $112.68 | 4,894.0000 | 98,900,000 | 22.70% | 0.00% |
| Sept. 12, 2023 | LYONS GARY A | Director | M | Non-Qualified Stock Option | 5000 | $12.98 | 5,000.0000 | 98,900,000 | 50.00% | 0.01% |
| Sept. 12, 2023 | LYONS GARY A | Director | M | Common Stock | 5000 | $12.98 | 208,697.0000 | 98,900,000 | 2.45% | 0.01% |
| Sept. 12, 2023 | LYONS GARY A | Director | S | Common Stock | 5000 | $115.02 | 203,697.0000 | 98,900,000 | 2.40% | 0.01% |
| Sept. 1, 2023 | LYONS GARY A | Director | M | Non-Qualified Stock Option | 5000 | $12.98 | 10,000.0000 | 98,900,000 | 33.33% | 0.01% |
| Sept. 1, 2023 | LYONS GARY A | Director | M | Common Stock | 5000 | $12.98 | 208,697.0000 | 98,900,000 | 2.45% | 0.01% |
| Sept. 1, 2023 | LYONS GARY A | Director | S | Common Stock | 5000 | $110.06 | 203,697.0000 | 98,900,000 | 2.40% | 0.01% |
| Sept. 1, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 824 | $110.93 | 17,263.0000 | 98,900,000 | 4.56% | 0.00% |
| Aug. 30, 2023 | Lippoldt Darin | Chief Legal Officer | G | Common Stock | 190 | $0.00 | 46,801.0000 | 98,900,000 | 0.40% | 0.00% |
| Aug. 30, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1295 | $106.90 | 4,898.0000 | 98,900,000 | 20.91% | 0.00% |
| Aug. 30, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1438 | $108.22 | 3,460.0000 | 98,900,000 | 29.36% | 0.00% |
| Aug. 28, 2023 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 1431 | $107.52 | 5,931.0000 | 98,900,000 | 19.44% | 0.00% |
| Aug. 21, 2023 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1600 | $107.40 | 36,436.0000 | 98,900,000 | 4.21% | 0.00% |
| Aug. 21, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 3198 | $107.38 | 29,521.0000 | 98,900,000 | 9.77% | 0.00% |
| Aug. 21, 2023 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 3198 | $107.37 | 9,638.0000 | 98,900,000 | 24.91% | 0.00% |
| Aug. 21, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 2132 | $107.39 | 46,991.0000 | 98,900,000 | 4.34% | 0.00% |
| Aug. 21, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 9328 | $107.40 | 499,754.0000 | 98,900,000 | 1.83% | 0.01% |
| Aug. 21, 2023 | Gano Kyle | Chief Business Development Off | S | Common Stock | 2132 | $107.41 | 130,250.0000 | 98,900,000 | 1.61% | 0.00% |
| Aug. 21, 2023 | Delaet Ingrid | Chief Regulatory Officer | S | Common Stock | 1404 | $107.42 | 4,645.0000 | 98,900,000 | 23.21% | 0.00% |
| Aug. 21, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 2132 | $107.41 | 18,087.0000 | 98,900,000 | 10.54% | 0.00% |
| Aug. 21, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1600 | $107.41 | 6,193.0000 | 98,900,000 | 20.53% | 0.00% |
| Aug. 21, 2023 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 2132 | $107.39 | 27,131.0000 | 98,900,000 | 7.29% | 0.00% |
| July 11, 2023 | POON CHRISTINE A | Director | A | Non-Qualified Stock Option | 16375 | $0.00 | 16,375.0000 | 98,900,000 | 9999.99% | 0.02% |
| May 17, 2023 | LYONS GARY A | Director | A | Restricted Stock Unit | 2100 | $0.00 | 2,100.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | SHERWIN STEPHEN A | Director | A | Restricted Stock Unit | 4199 | $0.00 | 4,199.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | Sharp Shalini | Director | A | Non-Qualified Stock Option | 4290 | $0.00 | 4,290.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | Sharp Shalini | Director | A | Restricted Stock Unit | 2100 | $0.00 | 2,100.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | RASTETTER WILLIAM H | Director | A | Non-Qualified Stock Option | 8579 | $0.00 | 8,579.0000 | 98,900,000 | 9999.99% | 0.01% |
| May 17, 2023 | POPS RICHARD F | Director | A | Restricted Stock Unit | 4199 | $0.00 | 4,199.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | Norwalk Leslie V | Director | A | Non-Qualified Stock Option | 4290 | $0.00 | 4,290.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | Norwalk Leslie V | Director | A | Restricted Stock Unit | 2100 | $0.00 | 2,100.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | MORROW GEORGE J | Director | A | Restricted Stock Unit | 4199 | $0.00 | 4,199.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | Mercier Johanna | Director | A | Non-Qualified Stock Option | 4290 | $0.00 | 4,290.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | Mercier Johanna | Director | A | Restricted Stock Unit | 2100 | $0.00 | 2,100.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | LYONS GARY A | Director | A | Non-Qualified Stock Option | 4290 | $0.00 | 4,290.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 1, 2023 | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 7625 | $12.71 | 0.0000 | 98,900,000 | 100.00% | 0.01% |
| May 1, 2023 | RASTETTER WILLIAM H | Director | M | Common Stock | 7625 | $12.71 | 47,085.0000 | 98,900,000 | 19.32% | 0.01% |
| May 1, 2023 | RASTETTER WILLIAM H | Director | S | Common Stock | 4300 | $101.43 | 42,785.0000 | 98,900,000 | 9.13% | 0.00% |
| May 1, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 11397 | $103.89 | 16,169.0000 | 98,900,000 | 41.34% | 0.01% |
| April 25, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 100 | $103.82 | 27,561.0000 | 98,900,000 | 0.36% | 0.00% |
| April 24, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 14400 | $103.48 | 26,644.0000 | 98,900,000 | 35.08% | 0.01% |
| April 19, 2023 | RASTETTER WILLIAM H | Director | M | Common Stock | 1610 | $12.71 | 35,632.0000 | 98,900,000 | 4.73% | 0.00% |
| April 19, 2023 | RASTETTER WILLIAM H | Director | S | Common Stock | 903 | $105.00 | 34,729.0000 | 98,900,000 | 2.53% | 0.00% |
| April 21, 2023 | RASTETTER WILLIAM H | Director | M | Common Stock | 10765 | $12.71 | 45,494.0000 | 98,900,000 | 31.00% | 0.01% |
| April 21, 2023 | RASTETTER WILLIAM H | Director | S | Common Stock | 6034 | $105.04 | 39,460.0000 | 98,900,000 | 13.26% | 0.01% |
| April 19, 2023 | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 1610 | $12.71 | 18,390.0000 | 98,900,000 | 8.05% | 0.00% |
| April 21, 2023 | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 10765 | $12.71 | 7,625.0000 | 98,900,000 | 58.54% | 0.01% |
| Feb. 13, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | A | Restricted Stock Unit | 21506 | $0.00 | 21,506.0000 | 98,900,000 | 9999.99% | 0.02% |
| Feb. 13, 2023 | ABERNETHY MATT | Chief Financial Officer | A | Restricted Stock Unit | 10264 | $0.00 | 10,264.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | ABERNETHY MATT | Chief Financial Officer | A | Stock Option | 63789 | $0.00 | 63,789.0000 | 98,900,000 | 9999.99% | 0.06% |
| Feb. 13, 2023 | BENEVICH ERIC | Chief Commercial Officer | A | Restricted Stock Unit | 8332 | $0.00 | 8,332.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | BENEVICH ERIC | Chief Commercial Officer | A | Stock Option | 51782 | $0.00 | 51,782.0000 | 98,900,000 | 9999.99% | 0.05% |
| Feb. 13, 2023 | Boyer David W. | Chief Corp. Affairs Officer | A | Restricted Stock Unit | 7245 | $0.00 | 7,245.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | Boyer David W. | Chief Corp. Affairs Officer | A | Stock Option | 45027 | $0.00 | 45,027.0000 | 98,900,000 | 9999.99% | 0.05% |
| Feb. 13, 2023 | Cooke Julie | Chief Human Resources Officer | A | Restricted Stock Unit | 6038 | $0.00 | 6,038.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | Cooke Julie | Chief Human Resources Officer | A | Stock Option | 37523 | $0.00 | 37,523.0000 | 98,900,000 | 9999.99% | 0.04% |
| Feb. 13, 2023 | Gano Kyle | Chief Business Development Off | A | Restricted Stock Unit | 10264 | $0.00 | 10,264.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | Gano Kyle | Chief Business Development Off | A | Stock Option | 63789 | $0.00 | 63,789.0000 | 98,900,000 | 9999.99% | 0.06% |
| Feb. 13, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | A | Stock Option | 133656 | $0.00 | 133,656.0000 | 98,900,000 | 9999.99% | 0.14% |
| Feb. 13, 2023 | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 8332 | $0.00 | 8,332.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 51782 | $0.00 | 51,782.0000 | 98,900,000 | 9999.99% | 0.05% |
| Feb. 13, 2023 | Onyia Jude | Chief Scientific Officer | A | Restricted Stock Unit | 10868 | $0.00 | 10,868.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | Onyia Jude | Chief Scientific Officer | A | Stock Option | 67541 | $0.00 | 67,541.0000 | 98,900,000 | 9999.99% | 0.07% |
| Feb. 13, 2023 | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 8453 | $0.00 | 8,453.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 52532 | $0.00 | 52,532.0000 | 98,900,000 | 9999.99% | 0.05% |
| Feb. 13, 2023 | Delaet Ingrid | Chief Regulatory Officer | A | Restricted Stock Unit | 5434 | $0.00 | 5,434.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | Delaet Ingrid | Chief Regulatory Officer | A | Stock Option | 33771 | $0.00 | 33,771.0000 | 98,900,000 | 9999.99% | 0.03% |
| Feb. 7, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 3248 | $102.30 | 470,930.0000 | 98,900,000 | 0.68% | 0.00% |
| Feb. 7, 2023 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 15360 | $102.42 | 33,501.0000 | 98,900,000 | 31.44% | 0.02% |
| Feb. 7, 2023 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 2030 | $102.29 | 19,705.0000 | 98,900,000 | 9.34% | 0.00% |
| Feb. 6, 2023 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1280 | $105.63 | 17,879.0000 | 98,900,000 | 6.68% | 0.00% |
| Feb. 8, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 700 | $104.11 | 4,755.0000 | 98,900,000 | 12.83% | 0.00% |
| Feb. 7, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 11497 | $102.42 | 4,127.0000 | 98,900,000 | 73.59% | 0.01% |
| Feb. 7, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 12801 | $102.41 | 15,624.0000 | 98,900,000 | 45.03% | 0.01% |
| Feb. 6, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 240 | $105.61 | 4,127.0000 | 98,900,000 | 5.50% | 0.00% |
| Feb. 8, 2023 | Gano Kyle | Chief Business Development Off | S | Common Stock | 980 | $103.99 | 128,096.0000 | 98,900,000 | 0.76% | 0.00% |
| Feb. 7, 2023 | Gano Kyle | Chief Business Development Off | S | Common Stock | 12801 | $102.41 | 127,216.0000 | 98,900,000 | 9.14% | 0.01% |
| Feb. 7, 2023 | Gano Kyle | Chief Business Development Off | S | Common Stock | 1623 | $102.29 | 115,719.0000 | 98,900,000 | 1.38% | 0.00% |
| Feb. 6, 2023 | Gano Kyle | Chief Business Development Off | S | Common Stock | 1600 | $105.64 | 114,257.0000 | 98,900,000 | 1.38% | 0.00% |
| Feb. 8, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 2274 | $104.30 | 491,365.0000 | 98,900,000 | 0.46% | 0.00% |
| Feb. 7, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 20482 | $102.43 | 489,322.0000 | 98,900,000 | 4.02% | 0.02% |
| Feb. 8, 2023 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 980 | $104.12 | 34,381.0000 | 98,900,000 | 2.77% | 0.00% |
| Feb. 6, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 3040 | $105.68 | 468,008.0000 | 98,900,000 | 0.65% | 0.00% |
| Feb. 8, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 911 | $104.08 | 44,973.0000 | 98,900,000 | 1.99% | 0.00% |
| Feb. 7, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 12801 | $102.42 | 44,157.0000 | 98,900,000 | 22.47% | 0.01% |
| Feb. 7, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1522 | $102.24 | 32,660.0000 | 98,900,000 | 4.45% | 0.00% |
| Feb. 6, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1041 | $105.80 | 31,290.0000 | 98,900,000 | 3.22% | 0.00% |
| Feb. 8, 2023 | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 701 | $103.83 | 42,337.0000 | 98,900,000 | 1.63% | 0.00% |
| Feb. 7, 2023 | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 12801 | $102.41 | 41,710.0000 | 98,900,000 | 23.48% | 0.01% |
| Feb. 7, 2023 | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 1015 | $102.16 | 30,213.0000 | 98,900,000 | 3.25% | 0.00% |
| Feb. 6, 2023 | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 801 | $105.82 | 29,300.0000 | 98,900,000 | 2.66% | 0.00% |
| Feb. 7, 2023 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 4508 | $102.30 | 6,525.0000 | 98,900,000 | 40.86% | 0.00% |
| Feb. 8, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 980 | $104.16 | 41,015.0000 | 98,900,000 | 2.33% | 0.00% |
| Feb. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 12801 | $102.41 | 40,135.0000 | 98,900,000 | 24.18% | 0.01% |
| Feb. 7, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1623 | $102.35 | 28,638.0000 | 98,900,000 | 5.36% | 0.00% |
| Feb. 6, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1121 | $105.80 | 27,176.0000 | 98,900,000 | 3.96% | 0.00% |
| Feb. 8, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 628 | $103.69 | 27,424.0000 | 98,900,000 | 2.24% | 0.00% |
| Feb. 8, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 700 | $103.95 | 28,052.0000 | 98,900,000 | 2.43% | 0.00% |
| Feb. 7, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 822 | $104.03 | 27,424.0000 | 98,900,000 | 2.91% | 0.00% |
| Feb. 7, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 12801 | $102.41 | 28,246.0000 | 98,900,000 | 31.19% | 0.01% |
| Feb. 7, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 913 | $102.25 | 16,749.0000 | 98,900,000 | 5.17% | 0.00% |
| Feb. 6, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 575 | $104.28 | 15,926.0000 | 98,900,000 | 3.48% | 0.00% |
| Feb. 6, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 640 | $105.47 | 16,501.0000 | 98,900,000 | 3.73% | 0.00% |
| Feb. 8, 2023 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 980 | $104.19 | 25,213.0000 | 98,900,000 | 3.74% | 0.00% |
| Feb. 7, 2023 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 11491 | $102.40 | 24,333.0000 | 98,900,000 | 32.08% | 0.01% |
| Feb. 7, 2023 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 12807 | $102.42 | 35,824.0000 | 98,900,000 | 26.34% | 0.01% |
| Feb. 7, 2023 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 2030 | $102.33 | 24,333.0000 | 98,900,000 | 7.70% | 0.00% |
| Feb. 6, 2023 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1280 | $105.67 | 22,507.0000 | 98,900,000 | 5.38% | 0.00% |
| Jan. 31, 2023 | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1250 | $109.97 | 30,357.0000 | 98,900,000 | 3.95% | 0.00% |
| Jan. 31, 2023 | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 1666 | $110.02 | 28,582.0000 | 98,900,000 | 5.51% | 0.00% |
| Jan. 31, 2023 | Onyia Jude | Chief Scientific Officer | S | Common Stock | 126 | $108.48 | 2,477.0000 | 98,900,000 | 4.84% | 0.00% |
| Jan. 31, 2023 | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1457 | $109.99 | 26,171.0000 | 98,900,000 | 5.27% | 0.00% |
| Jan. 31, 2023 | Cooke Julie | Chief Human Resources Officer | S | Common Stock | 916 | $108.48 | 15,926.0000 | 98,900,000 | 5.44% | 0.00% |
| Jan. 31, 2023 | Gano Kyle | Chief Business Development Off | S | Common Stock | 1541 | $109.98 | 112,820.0000 | 98,900,000 | 1.35% | 0.00% |
| Jan. 31, 2023 | GORMAN KEVIN CHARLES | Chief Executive Officer | S | Common Stock | 2707 | $110.08 | 465,278.0000 | 98,900,000 | 0.58% | 0.00% |
| Jan. 31, 2023 | ABERNETHY MATT | Chief Financial Officer | S | Common Stock | 1283 | $109.98 | 21,357.0000 | 98,900,000 | 5.67% | 0.00% |
| Jan. 31, 2023 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 1207 | $109.95 | 16,729.0000 | 98,900,000 | 6.73% | 0.00% |
| Jan. 31, 2023 | Boyer David W. | Chief Corp. Affairs Officer | S | Common Stock | 1104 | $109.92 | 3,911.0000 | 98,900,000 | 22.01% | 0.00% |
| Jan. 6, 2023 | BENEVICH ERIC | Chief Commercial Officer | M | Non-Qualified Stock Option | 400 | $43.24 | 53,143.0000 | 98,900,000 | 0.75% | 0.00% |
| Jan. 6, 2023 | BENEVICH ERIC | Chief Commercial Officer | S | Common Stock | 400 | $125.00 | 15,643.0000 | 98,900,000 | 2.49% | 0.00% |
| Jan. 6, 2023 | BENEVICH ERIC | Chief Commercial Officer | M | Common Stock | 400 | $43.24 | 16,043.0000 | 98,900,000 | 2.56% | 0.00% |
| Jan. 3, 2023 | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 15000 | $12.71 | 0.0000 | 98,900,000 | 100.00% | 0.02% |
| Jan. 3, 2023 | SHERWIN STEPHEN A | Director | S | Common Stock | 15000 | $118.85 | 25,055.0000 | 98,900,000 | 37.45% | 0.02% |
| Jan. 3, 2023 | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 15000 | $12.71 | 0.0000 | 98,900,000 | 100.00% | 0.02% |
| Jan. 3, 2023 | SHERWIN STEPHEN A | Director | M | Common Stock | 15000 | $12.71 | 40,055.0000 | 98,900,000 | 59.87% | 0.02% |
| Jan. 3, 2023 | SHERWIN STEPHEN A | Director | M | Non-Qualified Stock Option | 15000 | $12.98 | 0.0000 | 98,900,000 | 100.00% | 0.02% |
| Jan. 3, 2023 | POPS RICHARD F | Director | M | Common Stock | 15000 | $12.71 | 44,512.0000 | 98,900,000 | 50.83% | 0.02% |
| Jan. 3, 2023 | SHERWIN STEPHEN A | Director | S | Common Stock | 15000 | $118.87 | 25,055.0000 | 98,900,000 | 37.45% | 0.02% |
| Jan. 3, 2023 | POPS RICHARD F | Director | S | Common Stock | 15000 | $119.20 | 29,512.0000 | 98,900,000 | 33.70% | 0.02% |
| Jan. 3, 2023 | SHERWIN STEPHEN A | Director | M | Common Stock | 15000 | $12.98 | 40,055.0000 | 98,900,000 | 59.87% | 0.02% |